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Malnutrition is a significant healthcare concern across the globe. Though normally 
evocative of images of starvation or hunger, malnutrition also encompasses deficiencies 
of critical micronutrients such as zinc. Studies have implicated zinc malnutrition as a 
contributing factor to numerous developmental disorders and to diarrheal disease, one of 
the leading causes of death among children. However, current analytical techniques are 
inappropriate for measuring population-level deficiency in locations where these 
measurements are most needed. An effective test must be inexpensive to produce, require 
little training to administer and interpret, and be usable at point of care, eschewing 
sample transportation and expensive laboratory techniques. As obligate consumers of 
zinc, bacteria possess diverse cellular machinery to sense and regulate intracellular zinc 
concentrations in response to changes in their environment through allosteric 
transcriptional regulation of a variety of mechanisms of zinc influx, efflux, or 
sequestration. Bacteria are also relatively simple and inexpensive to produce at scale. 
This work describes efforts to leverage existing cellular mechanisms to sense and respond 
to zinc, to tie that response to heterologous pathways to produce human-readable 
pigmented metabolic outputs, to tune the machinery to respond to medically relevant 
levels in serum rather than levels originally useful to the bacterium, and to grow the 
resulting biosensor in human serum to demonstrate proof-of-principle of a whole cell zinc 
biosensor as the basis of inexpensive, colorimetric zinc assay, deployable directly at point 
of care with no additional analytic equipment. 
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CHAPTER 1. INTRODUCTION 
In this dissertation, I develop a whole-cell zinc biosensor as the basis of an assay for use 
in low-resource environments. The cost of current analytical techniques precludes their 
sustained widespread use for zinc status monitoring. Additionally, current approaches to 
whole-cell biosensors are not well adapted to deployment in the developing world. The 
World Health Organization has coined the acronym ASSURED to describe the 
characteristics of an ideal diagnostic test. Such a test would be: Affordable by those who 
need it, Sensitive, Specific, User-friendly (requiring minimal training), Rapid and Robust 
(does not require refrigerated storage), Equipment-free, and Delivered to those who need 
it1. I describe my contributions to tailor the design and implementation of synthetic, 
whole-cell biosensors to form the basis of an ASSURED zinc diagnostic test. 
1.1 Zinc Deficiency and Supplementation 
Zinc deficiency is most prevalent in developing nations, affecting an estimated 17% of 
the world’s population2. Of those affected, the most profound effects of zinc deficiency 
are seen in pregnant women and children under the age of five3. Deficient zinc status in 
pregnant women has been implicated in low birth weight, preterm delivery, and 
congenital abnormalities4. In 2004, low birth weight and prematurity were responsible for 
31% of neonatal deaths, which was 11% of all child mortality5. In those that survive, low 
birth weight and premature birth directly increase the risk of stunting or wasting (height-
for-age at less than two standard deviations from the mean or weight-for-height at less 
than three standard deviations from the mean, respectively), both of which directly 
increase the risk of child mortality6. After birth, continued zinc deficiency contributes to 
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stunting and increased incidence of diarrheal disease and pneumonia. Diarrheal disease is 
of particular importance, both because it is directly responsible for 16% of global child 
mortality5 and because it is implicated in zinc malabsorption7. In 2011, 116,000 under-5 
deaths (1.7% of 2011 child mortality) were attributable to zinc deficiency6. 
Estimates of zinc deficiency prevalence are based on an average dietary analysis, 
indicative of a major obstacle in developing a solution: reliable data on the zinc status of 
the world’s population is currently unavailable. Currently, the primary biomarker used to 
assess zinc status is serum or plasma zinc concentration, which is typically maintained at 
approximately 12 to 15 µM in healthy adults8. A review of zinc depletion and repletion 
studies in otherwise healthy adults concluded that serum zinc responds fairly rapidly (3-5 
weeks) to zinc-depleted diets and recovers to basal levels within a week of resumption of 
normal zinc intake8, indicating serum zinc concentration is an adequate indicator for zinc 
status and response to changes in dietary intake.  
Two potential strategies for addressing micronutrient deficiencies are biofortification and 
direct micronutrient supplementation. Biofortification is the selective breeding or genetic 
engineering of food crops to produce or accumulate more micronutrients. There have 
been a handful of successful efforts to engineer micronutrient accumulation phenotypes 
into food crops,9,10 and analysis of micronutrient biofortification has shown its general 
efficacy for providing provitamin A11. However, biofortification cannot alone meet 
requirements for treating acute severe zinc deficiency and for supplementation in 
pregnant and lactating women11. In an attempt to address the problem, studies have 
examined the effectiveness of direct zinc supplementation, mostly focusing on pregnant 
women and children under the age of 5. While the results have not always been 
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conclusive, broader meta-analyses of studies have evidenced the general efficacy of zinc 
supplementation. One such analysis found that zinc supplementation causes a statistically 
significant reduction in the incidence of diarrhea by 20%, of acute lower respiratory tract 
infections by 15%, and an overall reduction in mortality of 18% in children older than 12 
months12. A similar study found statistically significant reductions of diarrhea of 13% 
and pneumonia morbidity of 19% but failed to find a statistically significant decrease in 
all-cause mortality13. Multiple studies found small but significant increases in linear 
growth over the course of supplementation in young children12,14,15. The results for 
pregnant women were less conclusive, but supplementation has been found to reduce the 
incidence of preterm births by a statistically significant 14%. Troublingly, one trial of 
powdered micronutrient supplements comparing iron powders and combined iron and 
zinc powders to no-supplement controls found an increase of diarrhea and acute 
respiratory morbidities in children and failed to detect a statistically significant change in 
serum levels14, highlighting the need to thoroughly evaluate the efficacy of specific 
supplementation strategies. 
Though valuable information can be extracted from meta-analyses of many small scale 
studies, complete pictures of population zinc status remain elusive. One of the most 
prohibitive obstacles to achieving this is simply cost. Traditional lab testing requires 
constant refrigeration from the time the sample is taken to the time it is prepared for 
testing. Current state of the art testing involves flame atomic absorption spectroscopy14 or 
mass spectrometry, requiring established laboratories and skilled technicians. The cost 
and logistics associated with testing an arbitrary percentage of a population for zinc status 
with traditional methods are generally prohibitive. This is especially true in the 
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developing world and in the wake of significant natural disasters, where access to 
electricity may be limited or nonexistent. 
One potential solution is the widespread supplementation of zinc similar to current efforts 
in India to reduce anemia with the Weekly Iron and Folic Acid supplementation 
program16. As part of a broader assessment of undernutrition intervention strategies, a 
recent review estimated the cost of zinc supplementation in early childhood with 90% 
population coverage in countries representing 90% of the global deficiency burden would 
be $1.182 billion/year (2010 international dollars)17. This non-negligible cost associated 
with large-scale supplementation combined with the risk of potential side effects 
associated with particular strategies supports a more focused and informed approach; this 
in turn highlights the need for improved tests to aid in the design, implementation, and 
monitoring of such programs. Whole-cell biosensors have the potential to meet the 
economic and logistical constraints of population-level testing with an inexpensive and 
preservable bacterial chassis. Here, I apply synthetic biology to design a whole-cell 
biosensor for such testing. 
1.2 Synthetic Biology and Whole-Cell Biosensors 
Synthetic biology is a broad field involving the design of new biological components or 
redesign of existing systems such as reaction networks, genetic circuits, or whole cells18. 
Though synthetic biologists may have fundamentally different goals—pure biology, 
metabolic engineering, biocomputing, etc.—they all view the underlying biology of their 
chosen systems as a tool to achieve novel functionality or to solve specific problems. 
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An important concept in synthetic biology is the genetic circuit, a collection of genetic 
elements designed to produce some desired output by modulating transcription, 
translation, protein interactions, or other regulatory phenomena. Early work saw the 
construction of simple artificial circuits like genetic toggle switches19 or basic digital 
logic gates, opening up the possibility for biological computation along the lines of 
traditional digital processors. To that end, a variety of logic gates have been successfully 
demonstrated in vivo20. Serious hurdles still exist to realizing the goal of whole-cell 
biocomputing, such as the intrinsic noisiness of most biological systems and the limited 
number of available and appropriate regulatory elements, but efforts to solve both of 
those problems are ongoing. 
Genetic circuits lay the foundations for the concept of the whole-cell biosensor. These 
‘devices’ are entire organisms with the ability to produce some measurable signal to 
provide information about a system of interest. One of the most significant advantages of 
whole-cell sensors is that they are self-replicating, drastically simplifying production, 
reducing cost, and permitting easy scale up. In contrast to traditional analytical 
techniques, biosensors need not require expensive equipment if designed appropriately. 
They are also able to provide information on the bioavailability of analytes rather than 
overall concentration, a property largely responsible for their widespread appeal in 
environmental monitoring, where they can be used to more directly assess the risk of 
pollutants to ecosystems21,22. 
Though they likely did not consider themselves to be synthetic biologists, early 
geneticists pioneered some of the most fundamental techniques involved in genetic 
reporting and the manipulation of genetic systems. Early genetic work exploring 
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expression of proteins of unknown function and regulation used reporter gene fusions 
with unknown operons to investigate their response to different chemicals or growth 
conditions. The concept of whole-cell biosensors was also pioneered before the deliberate 
design of genetic reporting circuits. A sensor made from Photobacterium phosphoreum23, 
a bioluminescent marine organism, was used commercially to assess nonspecific toxicity 
in samples. Bioluminescence levels were compared to a control, using a reduction in 
signal as a rough indicator of sample toxicity. Other generic stress sensors were 
constructed through the translational coupling of reporters to known biological stress 
response systems both to investigate basic biology and to aid in developing other generic 
toxicity assays.  
Though there is undoubtedly utility in nonspecific sensors (e.g., the generic stress 
response sensors described above), one significant promise of biosensors is the detection 
of specific analytes of interest by exploiting the exquisite sensing mechanisms 
microorganisms have evolved to adapt to different environments. Isolating these 
regulatory elements and coupling them to reporters in their native organism or in a well-
characterized chassis like E. coli is a common approach which has seen a wide variety of 
uses from monitoring environmental pollutants21,24,25 to enabling high throughput 
screening for drug design26,27. Increasing understanding of regulatory mechanisms has 
allowed both rational design26,28 and combinatoric29,30 generation of new functionality. 
Indeed, some families of sensor-regulators have modular domains29,31,32, potentially 
allowing the generation of multiple orthogonal artificial regulatory systems. 
Upon sensing and processing a signal, the biosensor must produce some detectable 
output. There are a number of available reporting systems currently in use, each with 
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their own sets of advantages and disadvantages. A common, general use reporter is the 
fluorescent protein, which offers simple detection of sensor output with widely available 
fluorimeters. Many different types of fluorescent proteins have been engineered for 
application in diverse conditions. Other reporter systems increasingly used for biosensor 
applications are luciferases, enzymes which catalyze light-producing reactions. These 
offer high quantum yield, allowing excellent sensitivity with appropriate detectors. The 
miniaturization of charge coupled device (CCD) detectors has encouraged the use 
bioluminescence-based reporters, improving their prospects of incorporation into portable 
whole-cell detection devices.  
A more indirect approach to reporting uses a protein’s enzymatic activity to convert a 
substrate to something easily detectible, such as a fluorescent or pigmented product. 
These were some of the earliest reporters used, and include E. coli-derived 
chloramphenicol acetyltransferase and β-galactosidase23. Enzymatic assays are still 
commonly used but require the addition of reagents to produce a signal which must still 
be measured with equipment like fluorimeters or spectrophotometers to produce 
quantitative measurements. A related approach is the use of enzymes that produce 
pigments as secondary metabolites. These do not require the addition of substrates, but 
the rate of pigment production is tied to the cell’s metabolism, sometimes making it 
difficult to directly correlate inferred enzymatic activity with expression levels. Many 
examples of biosensors reporting with pigment production are available33,34, but 
quantification often presents a challenge, requiring quantitative extraction or limiting the 
biosensors to more qualitative applications such as blue/white screening or other binary 
tests. 
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1.3 Zn2+-Responsive elements 
The construction of biosensors relies on the ability to control the transcription of circuit 
elements and the expression of reporter genes in response to the signal of interest. My 
efforts were primarily concerned with the determination of zinc concentration. 
Fortunately, much work has been done to elucidate the metalloregulatory responses of 
many organisms, including E. coli. Zinc is an important component of biological 
chemistry, with over 300 metalloenzymes in E. coli known to form complexes with zinc 
as structural or catalytic elements35. Unsurprisingly, E. coli possesses an impressive array 
of proteins dedicated to sensing, importing, and exporting zinc and other metal ions. 
These systems allow the bacterium to survive in environments with a wide range of zinc 
concentrations. 
E. coli typically maintains intracellular zinc concentrations around 200 µM36 in 
laboratory conditions. Nevertheless, the bacterium can grow in media with zinc 
concentrations ranging from ~30 nM37 to ~1 mM38, depending on the other components 
of the growth media. It accomplishes this through a combination of constitutive and 
inducible ion-transport systems including but not limited to zntA, zupT, zitB, znuABC, and 
zinT. The gene zntA encodes a zinc- and cadmium- specific p-type ATPase positively 
regulated by the transcriptional activator ZntR in response to increased zinc stress31. The 
gene zupT encodes a constitutive36, non-specific metal transporter capable of importing 
zinc ions39. ZitB is a cation efflux diffusion facilitator, dependent on the proton gradient. 
The znuABC operon codes for three proteins in a zinc import system: ZnuA is a 
periplasmic zinc binding protein, ZnuB is an integral membrane protein, and ZnuC is an 
ATPase. The expression of the znu gene cluster is controlled by Zur, a transcriptional 
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repressor which binds DNA in high zinc environments. ZinT, also negatively regulated 
by Zur, is a high-affinity periplasmic zinc binding protein involved in either direct 
transport across the inner membrane or the delivery of zinc for binding to membrane 
proteins. 
The response of E. coli to both zinc starvation and poisoning has been investigated 
through transcriptomics35,37,38 and proteomics39,40, demonstrating many differentially 
regulated genes. Unfortunately, differing culture conditions (batch vs. chemostat), 
methods of zinc depletion (rigorous media preparation vs. chelation), and analytical 
techniques make it difficult to isolate the effects of zinc alone, with much of the 
differential regulation not consistent across studies. A great deal is still unknown about 
zinc regulation in E. coli, but both ZntR and Zur are two well-characterized zinc-
responsive transcription factors. Knowledge of the operator sequence for Zur in the znu 
operon led to the discovery that zinT is also regulated by Zur37. The promoter PzntA has 
been used in biosensors for cadmium, mercury, and zinc in wastewater22,25,41, but no 
application has gone beyond the direct fusion of bioluminescent or fluorescent proteins to 
promoters. These studies did not go further than cloning a fluorescent protein under 
control of PzntA and measuring zinc, cadmium, and lead response in LB41, or using 
genomic ZntR and PzntA to assess response two 13 environmental candidates with 
bioluminescence22. The most in-depth use case investigated was the use of PzntA 
controlling expression of luciferase genes to monitor wastewater for the presence of 
cadmium, mercury, and copper in which a fluidics device was constructed and 
successfully tested to mix wastewater and nutrients for online monitoring of a wastewater 
stream25, demonstrating that this promoter can be implemented usefully in whole-cell 
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biosensors, but no complex tuning was performed. Cells were still used primarily to alert 
of the presence of some (nonspecific) contaminate. Investigation into modification of any 
of these systems to change promoter response to zinc by altering transcription factor gene 
dosage, decoy site abundance, and other zinc regulatory machinery has heretofore been 
absent. 
1.4 Pigments 
Much of the recent work on whole-cell biosensors has concerned platforms for high 
sensitivity bioluminescence detection for field or online applications42. Increasing 
portability and minimizing assay time, while undoubtedly critical for most applications, 
do nothing to enhance the prospect of minimal cost assays if the improvements come 
with the requirement of integrated CCD detectors, microfluidics, or other expensive 
alternatives. To develop the most economical solution for a zinc status assay, reporting 
mechanisms should be developed that require no specialized detectors; reporter systems 
based on the production of multiple pigments represent a promising strategy in this 
regard. Such approaches offer the advantage of creating discrete changes in coloration 
detectable with the naked eye while avoiding the subjectivity of visual quantification of 
the amount of a single pigment. This work will utilize two families of pigments: those 




Figure 1: Simplified map of the vio (a) and crt (b) biosynthesis pathways beginning 
with the last metabolite native to E. coli. Reactions are labeled with enzyme if 
known or ‘s’ if spontaneous. 
 
Violacein is a pigmented secondary metabolite produced by a number of bacteria. Natural 
production of the pigment is thought to protect bacteria from predation by organisms to 
which violacein is toxic. Its selective antibiotic activity may also reduce competition in 
the environment43. The pigment is of scientific interest primarily due to its antibiotic and 
antitumor44 activity and because its biosynthetic pathway produces intermediates similar 
to other medically important compounds such as rebeccamycin and staurosporine45. The 
pigment is produced through a series of enzymatic, autooxidation, and 
autodecarboxylation reactions directed by the five genes in the vio operon. The 
biosynthetic pathway involved has been almost completely mapped, revealing a unique 
biosynthetic mechanism, a 1,2-indole shift, found in no other known pathway to date. 
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Though its mechanism of antibiotic activity is unknown, violacein can be stably 
overexpressed in E. coli46, albeit only with especially stable expression plasmids for toxic 
heterologous protein production. Critically, the pathway has multiple colored 
intermediate side products43, allowing several reporters to be produced by controlling the 
expression of just a handful of vio genes. A simplified map of the vio biosynthetic 
pathway is presented in Figure 1a. 
The carotenoid (Figure 1b) pathway is another source of pigments including the pink-red 
lycopene, the orange β-carotene, and the yellow zeaxanthin. The pathway is present in 
numerous plants and bacteria, where it serves a number of purposes. The production of 
carotenoids has been extensively studied, both for useful properties of the carotenoids 
themselves and the value of many other industrial or medically important isoprenoids 
(compounds based on multiple isoprene units) such as the antimalarial drug artemisinin 
and provitamin A, which is a group of carotenoids including β-carotene. In order to make 
biological production of these compounds feasible, both the carotenoid biosynthesis 
pathway and upstream precursor pathways in S. cerevisiae and E. coli have been the 
focus of metabolic engineering efforts to increase production rates and maximum titer47-
50, the results of which could prove useful in reducing assay time in pigment-based 
biosensors. 
To date, the use of pigments as reporters in whole-cell biosensors has been limited. Some 
successful attempts have correlated degree of pigmentation with qualitative analyte 
concentration by examining degree of coloration of the culture34; however, the majority 
of the focus in biosensor research has been on producing rapid, quantitative output. By 
employing multiple color outputs, we can implement pigment-based whole-cell sensors 
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to provide semi-quantitative reporting of defined analyte concentration ranges without the 
use of additional equipment. 
1.5 Overview 
The promise of biosensors presents a unique opportunity to bring the power of synthetic 
biology to bear on significant global humanitarian problems. Though accurate, current 
testing methods are not capable of meeting the economic and logistical constraints of 
population-level micronutrient status testing. Efforts to combat zinc deficiency have been 
hampered by insufficient information on the extent of the problem and the uncertainty 
about the most effective methods of treating zinc deficiency in the developing world or in 
the wake of emergency humanitarian crises. Pigment-based bacterial biosensors offer the 
potential for an inexpensive zinc status assay that, when combined with other established 
low-resource sample preparations such as centrifuges based on egg beaters51, centrifuges 
based on children’s toys52, or paper-based53 separation technologies, would require no 
laboratory equipment, electricity, or sample transport and minimal training to administer. 
This technology could facilitate consistent monitoring of zinc status, aiding not only in 
the identification of population-level deficiencies, but ultimately in the development of 
supplementation strategies; these capabilities would in turn allow more targeted 
interventions by identifying explicitly deficient subpopulations, eliminating a portion of 




CHAPTER 2. USING METABOLISM TO AUGMENT 
BIOSENSOR TUNING 
Portions of this chapter are reproduced from my publication “Precise metabolic 
engineering of carotenoid biosynthesis in Escherichia coli towards a low-cost 
biosensor”54 in Metabolic Engineering with permission from the publisher.  
2.1 Introduction 
Metabolic engineering has played a key role in advancing a number of critical 
biotechnological research areas and applications, but there remain numerous areas where 
control of metabolism has not been leveraged to solve critical problems, such as enabling 
biosensors for applications like blood micronutrient measurement at a population scale. 
The biofuels55-57, pharmaceutical58,59, and specialty and commodity chemicals60,61 
applications of metabolic engineering are well-known. Moreover, the techniques of 
metabolic engineering have been used to engineer plants and foodstocks to help battle 
problems such as nutrient and micronutrient deficiency, with one of the most prominent 
examples being the development of Golden Rice9,10. We sought to investigate using 
metabolic engineering in a novel application—to tune the output of a pigment-based 
biosensor independent of the transcriptionally based sensor-actuators. 
This work has potential broader applications to any biosensor using pigments as a 
reporting mechanism, but here we investigated altering metabolism and adjusting 
metabolic precursor availability as a means of enabling or improving the function of the 
carotenoid pathway as a reporting mechanism for the zinc biosensor. Previous 
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technologies for sensing zinc produced fluorescence or luminescence proportional to zinc 
concentrations41,62; while such assays give the potential for quantitative results, they 
require specialized equipment to detect and quantify these readouts that limit application 
in low-resource areas. Instead, we designed our assay to use pigment production as a 
readout, removing the need for quantification. Pigment production is performed by 
heterologous genes expressed in E. coli under the control of zinc-responsive transcription 
factor/promoter systems. We further sought to make the color outputs as discrete as 
possible, transitioning sharply from one color to another so as to remove potential 
ambiguity from the reading.  
 The pigments used for this biosensor were the red and orange carotenoids 
lycopene and β-carotene and the purple pigment violacein, each of which have previously 
been the targets of metabolic engineering efforts whose results and insights have 
contributed to the engineering efforts described here. There has been extensive work on 
the engineered overproduction of lycopene and other isoprenoids63-65, as they have 
significant industrial value as chemicals, and isoprenoids are a precursor to yet other 
extremely valuable chemicals, including taxol50. Violacein has also been the subject of 
significant metabolic engineering efforts66-68, both due to the novelty and complexity of 
the pathway that produces it, and for its potential value as an antimicrobial or antitumor 
drug. In these cases, the chief goal of the metabolic engineering efforts to date has been 
high titer production with the downstream goal of purification. For our application, 
though, tightly controlled expression rather than high titer was the primary goal of our 
metabolic engineering efforts. 
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An effective bacterial-based, pigment-producing diagnostic for our application required 
(1) sufficient pigment to be visible to the naked eye (2) in a reasonable amount of time 
(3) with sufficient control over production of all pigments to enable discrete color states. 
The first two of these criteria directly relate to traditional metabolic engineering efforts, 
though with a greater emphasis on productivity to meet a minimum (visible) titer rather 
than maximizing titer. Meeting the third criterion was the most challenging for the final 
engineering implementation of the sensor, and is the focus of this chapter. We chose to 
use two pigments (lycopene and β-carotene) from the linear carotenoid pathway with the 
expectation that it would facilitate the creation of discrete color states: each molecule of 
red lycopene could be stoichiometrically converted into orange β-carotene upon induction 
of the appropriate enzyme by the presence of sufficient zinc, leaving no residual red color 
in the orange state. This advantage is also a potential challenge, though, if that zinc-
inducible promoter has substantial baseline uninduced transcription of that enzyme, 
which could prevent accumulation of lycopene. However, our application constrains 
selection of promoters: the promoter must be zinc-inducible, and there are few well-
characterized zinc-inducible promoters. 
 Here, we present a proof-of-principle, metabolically engineered bacterial 
biosensor with pigment outputs that require no equipment for measurement and 
interpretation, for potential use in micronutrient (zinc) blood testing. We present the 
initial results from a straightforward implementation of the desired biosensor, which 
indicated the need for metabolic engineering in order to achieve the desired discrete color 
states. We explore multiple avenues to achieve the desired outcome, and we assess which 
are necessary and sufficient for this specific application. The trends identified in 
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optimizing the construction of the sensor are likely generalizable to similar pigment-
based micronutrient sensors or whenever promoter selection is constrained. As metabolic 
engineering finds more diverse applications, it is likely that techniques to not just 
optimize production but tightly control it will be increasingly necessary. 
2.2 Materials and methods 
2.2.1 Materials 
T4 DNA ligase, T5 exonuclease, Taq ligase, Phusion polymerase, Q5 polymerase, and 
restriction endonucleases were purchased from New England Biolabs (Ipswich, MA, 
USA). QIAprep Spin Miniprep Kits, QIAquick Gel Extraction Kits,and QIAquick PCR 
Purification Kits were purchased from QIAGEN (Valencia, CA, USA). Lycopene (98%) 
was purchased from Cayman Chemical (Ann Arbor, MI, USA). β carotene (97%) was 
purchased from TCI America (Portland, OR, USA). SC-Ura amino acid supplement was 
purchased from Sunrise Science (San Diego, CA, USA). 
2.2.2 Carotenoid extraction 
1 mL of bacterial culture was pelleted at 16,000 rcf for 7 minutes. Cell pellets were 
resuspended in 50 µl of water from a MilliQ water handling system (EMD Millipore). 
Carotenoids were extracted with 1 mL of acetone at 55 C for 20 minutes with continuous 
shaking in a Grant Thermoshaker at 1400 rpm. Cellular debris was pelleted at 16,000 rcf 
and the supernatant was removed for analysis. All carotenoid extraction was carried out 
in low light conditions. 
2.2.3 HPLC analysis 
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All HPLC analysis was conducted on a Shimadzu LC-20AD Liquid Chromatograph 
using a Shimadzu C18 4.6 mm x 50 mm column with a 5 µm particle size and a SPD-
20A UV-Vis detector. The instrument was run with a flow rate of 0.6 mL/min and a 
solvent ratio of 90:10 acetonitrile:THF. Retention times and intensities were compared to 
analytical standards spiked into control extractions from DH10B cells and calibration 
curves to convert peak areas to analyte concentrations were constructed. 
2.2.4 Cell Culture 
For eGFP library expression, freshly transformed DH10B colonies were inoculated in 
triplicate into 5 mL LB media and were grown for 24 hours. 125 µL of each culture was 
aliquotted into 96-well plates and measured on a Biotek Synergy H4 plate reader for 
OD600 and fluorescence at 488 nm excitation and 509 nm emission. Samples were also 
analyzed on a BD Accuri C6 flow cytometer. 
For zinc carotenoid experiments, each strain was inoculated from freshly transformed 
colonies in triplicate into LB and minimal media at the following concentrations of 
supplemented ZnSO4: 0, 50, 500, 1000 µM (LB) and 0, 5, 50, 500 µM (Minimal). 
To allow zinc titration, a modified minimal media based on M9 but lacking inorganic 
phosphate was developed containing the following: 2.5 g/L beta-glycerophosphate 
pentahydrate, 1.64 g/L KCl, 4.5 g/L NaCl, 1 g/L NH4Cl, 3.9 g/L MES, 2 mM MgSO4, 0.1 
mM CaCl2, 0.01% thiamine, 0.6% glycerol, and 1.92 g/L SC-Ura amino acid supplement. 
pH was adjusted to 7.4. The following antibiotics were used as needed for selection: 
carbenicillin (100 µg/mL), chloramphenicol (34 µg/mL), kanamycin (30 µg/mL). 
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Gradient agar plates were made by allowing supplemented media to gel on inclined petri 
dishes, forming wedges. The plates were then laid flat and filled in with unsupplemented 
media. LB gradient plates were made with three sections: supplemented 10 µM TPEN, 
LB alone, and LB with 250 µM ZnSO4. Minimal gradient plates were made with two 
sections: plain minimal medium and 250 µM ZnSO4. TPEN was used to simulate zinc 
deprivation in rich media. 
2.2.5 Cloning and construct assembly 
Most construct assembly was carried out via restriction endonuclease digestion of 
components and subsequent ligation and transformation following the BioBricks 
idempotent standard assembly. Constructs in pCC1FOS were first assembled as above in 
BioBrick-compliant vectors. These were then digested with NotI and ligated into 
pCC1FOS. 
The initial attempted multi-state pigment-producing construct was assembled via Gibson 
assembly69. This method was also used to add ssrA tags to eGFP and CrtY and to remove 
illegal restriction sites for BioBrick standard assembly from coding sequences for eGFP, 
zur, and tetR.Plasmids and regulatory sequences 
2.2.6 Plasmids and regulatory sequences 
A list of all vectors used is provided in Table 1, along with their expected copy number. 
ZntR, Zur, and PznuC were amplified from DH10B genomic DNA. pJBEI-6409 was 
obtained from Addgene (Cambridge, MA, USA) and is referred to here as pJBEI-MEV. 
PzntA sequence was synthesized by Genewiz (South Plainfield, NJ, USA). eGFP was 
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provided by Julie Champion, and pCC1FOS was provided by Brian Hammer. All other 
parts, including ribosomal binding sites, promoters, and pigment biosynthesis genes, were 
obtained from the Registry of Standard Biological Parts and were sequence-confirmed 
before use. 
 







pJBEI-MEV Medium p15A 
pSB1C3 High PUC colE1 
pSB1AK3 High PUC colE1 
pSB3C5 Low p15A Mutated 





2.2.7 Strain naming convention 
Fluorescence library members were named by concatenating the name or Parts Registry 
part number of the promoter, the last two digits of the Parts Registry part number for the 
ribosomal binding site, and then potentially three letters indicating whether a strong 
(LAA) or weak (DAS) ssrA protein degradation tag was added (AANDENYALAA or 
 21 
AANDENYADAS). Carotenoid test parts were named by concatenating the Parts 
Registry part number of the RBS in front of crtY, an indicator of whether there was a 
degradation tag on crtY (LAA, DAS, or nothing), and the last three characters of the 
name of vector the construct was cloned into (1C3, 3C5, 6A1, or FOS). The presence of 
+J indicates the carotenoid construct was co-transformed with pJBEI-MEV. 
2.3 Results and Discussion 
To move towards the goal of population-scale monitoring of blood micronutrient status 
(specifically zinc), a low-cost, portable, equipment-free approach is necessary. The 
overall workflow of the final envisioned biosensor is illustrated in Figure 2A: sensor cells 
would be lyophilized or otherwise preserved for long term storage. A blood sample 
would be separated in the field via a low-cost, equipment-free approach such as the egg 
beater centrifuge51 or paper centrifuge52. The resulting plasma would then be added to the 
preserved cells (potentially with additional, zinc-free defined medium), and the cells 
would produce different pigments in response to the levels of zinc in the physiologically 
relevant range of 8-15 µM8 corresponding to normal, borderline, and low levels of zinc. 
To implement the desired functionality, we designed a circuit using heterologous pigment 
production pathways driven by zinc-responsive transcription factor/promoter pairs 
present in E. coli (Figure 2B). The first heterologous pigment production pathway was 
the purple violacein biosynthesis pathway, which uses the vioABCDE operon (originally 
derived from Chromobacterium violaceum) to produce violacein from endogenous 
tryptophan. The second pigment production pathway was carotenoid biosynthesis, which 
uses the crtE, crtB, and crtI genes to produce red lycopene starting from endogenous 
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FPP, and uses crtY to produce orange β-carotene from lycopene; these genes were 
originally derived from Pantoea ananatis. Expression of these pigment production 
pathways was driven by two endogenous E. coli zinc-responsive promoter/transcription 
factor pairs, PznuC/Zur and PzntA/ZntR, which control expression of zinc importer and 
exporter genes, respectively. (Zur is a zinc-activated transcriptional repressor and ZntR is 
a zinc-activated transcriptional activator.) Previous work38 suggested that Zur is able to 
fully repress expression from PznuC at approximately 10 µM zinc, while induction of 
transcription from PzntA should begin at least by 100 µM zinc (preliminary results 
suggested induction by 10 µM) with full induction not until approximately 1.1 mM31. 
These pieces were then combined together such that the circuit would provide discrete 
color states of purple, red, and orange depending on the zinc concentration of the sample. 
PznuC was used to drive expression of vioABCDE and PzntA was used to drive expression 
of crtY; zntR and zur were expressed from the same plasmid using their genomic 
promoters, while crtEBI was expressed from a mutated pλ-based, extremely weak 
promoter (avoiding toxic expression; discussed in Chapter 4). At low zinc concentrations 
(below 10 µM), transcription from PzntA would be low and transcription from PznuC would 
be induced, resulting in violacein biosynthesis (which is so dark as to visibly overwhelm 
minor lycopene production). At borderline levels of zinc (approximately 10 µM), Zur 
would become activated and repress expression from PznuC. This would repress 
expression of the violacein biosynthesis operon, but expression of crtY to produce β-
carotene would not be sufficiently induced, resulting in the production of only the red  
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Figure 2: An initial synthetic biology-based zinc biosensor for application to 
equipment-free blood tests. a) A schematic of the workflow envisioned for the 
eventual final implementation of the diagnostic biosensor. Cells from general 
culture (bottom) are lyophilized for long-term storage. A blood sample (top) is 
centrifuged using minimal equipment on-site technique such as an egg beater70 or 
paper centrifuge52 to separate plasma, which is then added to the stored cells. These 
cells then produce pigment (right) based on the level of zinc in the plasma sample. 
Physiological concentrations of zinc are included for reference. b) Schematic of the 
circuit design intended for implementation of the initial biosensor. Transcriptional 
regulators ZntR and Zur are expressed on the same plasmid as the construct with 
violacein synthesis driven by the zinc-repressible PznuC promoter, lycopene synthesis 
driven by a weak promoter, and the gene catalyzing the transformation of lycopene 
to β-carotene driven by the zinc-inducible PzntA promoter. The bolded zinc 
annotation for PzntA indicates that activation by zinc happens at higher 
concentrations than for PznuC. c) Streak from a zinc gradient plate demonstrating 
direct transition from purple to orange without an intervening lycopene-dominated, 
red state. (Image contrast was adjusted to reduce the background from the agar 
plate; the original image is included in Figure 26) 
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pigment lycopene. At normal levels of zinc (over 10 µM), violacein production would 
still be repressed, but ZntR would then be activated and crtY expression would increase, 
facilitating the transformation of lycopene to β-carotene and yielding only orange 
pigment. 
2.3.1 Initial circuit restricted to two distinct color states 
We implemented the circuit design and expressed it on a high copy number plasmid in E. 
coli. The entire construct was sequence confirmed. The behavior of the implemented 
construct is shown in Figure 2c, as a streak on a zinc gradient plate. There is a clear, 
fairly sharp transition between two color states, purple (low zinc) and orange (high zinc), 
but no observable red (intermediate zinc) state. This behavior provides a number of key 
insights. First, the fact that crtEBI is very weakly and constitutively expressed is not a 
problem, as the dark color produced by violacein overwhelms any potential background 
signal of carotenoid production. Next, the repression of violacein production at higher 
zinc concentrations is sufficient to allow for the carotenoid production to be visible 
without any interference from leakiness of the PznuC promoter. Finally, the basal 
uninduced expression of crtY from PzntA at low and intermediate zinc levels is too great to 
allow precise control over the pathway, as lycopene is converted to β-carotene even at 
zinc levels where crtY should not be strongly induced. 
2.3.2 Absence of a lycopene-only state is due to overlap in expression regimes 
To investigate the cause of the absence of a lycopene-only state, we implemented a 
fluorescence-based construct to assess the induction and repression of PzntA and PznuC, 
respectively. Figure 3a shows the structure of this construct: RFP expression is driven by 
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the zinc-inducible PzntA promoter, while GFP expression is driven by the zinc-repressible 
PznuC promoter, with the transcription factors for each promoter (ZntR and Zur, 
respectively) constitutively expressed from the same high-copy plasmid. Figure 3b shows 
the quantitative results of GFP and RFP expression from the promoters. It is thus clear 
that while PzntA and PznuC can be significantly induced and repressed, respectively, there is 
some overlap in their expression regimes, whether due to their response curves to zinc or 
due to baseline leaky expression. It is worth noting that most of the repression from PznuC 
occurs over the low concentrations of zinc, yet there is clearly (Figure 2c) a regime where 
violacein is not visible. Since violacein is much easier to detect visually than the 
carotenoids, this suggests that even though there is measurable fluorescence (and thus 
measurable leakiness) for this test construct, the production of violacein corresponding to 
that level of fluorescence would not be visually detectable. Combined with knowledge 
that the maximum repression of PznuC has been shown to happen at the bottom end of the 
PzntA induction range, this supports the idea that the reason why no lycopene-only state is 
detectable is that crtY expression is too great at low zinc levels, rather than vioABCDE 
expression being too great at higher zinc levels. Expression of mRFP from PznuC and PzntA 
on parallel regulated constructs suggests that visibly there is likely to be a significant 




Figure 3: Fluorescence reporter construct shows overlap in PznuC and PzntA 
expression. a) Schematic of the reporter construct used to simultaneously measure 
expression from PznuC and PzntA promoters. The transcription factors regulating 
expression from each promoter were included on the plasmid. The bolded zinc 
annotation for PzntA indicates that activation by zinc happens at higher 
concentrations than for PznuC. b) Expression from each promoter in arbitrary units 
specific to each fluorescent protein (RFP is right axis, GFP is left axis). There is 
significant induction of expression from PzntA even at low levels of added zinc and 
significant repression of expression from PznuC, suggesting that the baseline 
expression of crtY may be the cause of a lycopene-only state being difficult to 
capture. Error bars represent standard error of the mean. 
 
2.3.3 Fluorescence reporter library for characterisation of post-transcriptional control 
In order to gain sufficient control over the lycopene to β-carotene reaction step to 
generate a three-color-state sensor, we then sought to adjust post-transcriptional 
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regulatory elements. Specifically, modification of ribosomal binding sites and tagging of 
proteins for degradation were identified as the simplest approaches to decrease the level 
of CrtY at low levels of zinc. To do this most efficiently, we characterized the impact of 
multiple regulatory elements within our specific host strain using an eGFP reporter. We 
also sought to characterize the strength of multiple potentially constitutive promoters 
(which could drive expression of the zinc-responsive transcription factors) and the 
strength of our zinc-responsive promoters (without coexpressed regulators). This 
characterization was intended to facilitate more rational and focused selection of 
regulatory elements for the final sensor construct rather than performing combinatorial 
syntheses that would be challenging based on product toxicities; the results of the 
characterization are presented in Figure 4. 
Taken together, manipulating promoters and post-transcriptional regulatory sequences 
yielded over five orders of magnitude of variation of fluorescence (Figure 4a). Each level 
alone (transcriptional and post-transcriptional) offered at least three orders of magnitude 
dynamic range, with low-fluorescence measurements being confounded by limits of 
detectability even at high plate reader gain settings.  
Measurements of promoter strength across multiple sets of post-transcriptional regulatory 
sequences provided information for later selection of promoters (i.e., for zntR and zur) 
and provided an estimate of the strength of the PznuC and PzntA promoters. Unsurprisingly, 
the Pλ-based promoters (R0040 and R0011) were the strongest. Known weaker promoters 
(J23117 and J23116) performed roughly as expected, though the difference between these 
two promoters was greater than previously reported. We used the expression levels of 
these promoters to characterize some of the transcriptional behavior of the two inducible 
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promoters. Since these constructs had no supplementary regulator expression (i.e. Zur or 
ZntR) in order to be consistent with the rest of the library, the expression from PznuC is 
indicative of essentially unrepressed transcription, while expression from PzntA is 
indicative of essentially uninduced transcription. We found that baseline expression from 
PzntA was stronger than at least one known weak constitutive promoter, J23117. This 
suggests that the underlying reason for the lycopene state being difficult to stabilize may 
be that the baseline transcription from PzntA is sufficiently high to result in significant 
production of CrtY. 
Changing ribosomal binding sites (RBSs) also enabled many orders of magnitude of 
reduction for overall gene expression. Figure 4b demonstrates the impact of using four 
different ribosomal binding sites taken from the Registry of Standard Biological Parts: 
B0031-B0034. The patterns of RBS strength as measured here were qualitatively 
consistent with previously measured values, with a few exceptions. First, we found 
B0031 was slightly stronger than B0032 rather than vice versa; this was consistent across 
all promoter strengths. Second, we found that expression from B0034 was usually not 
much stronger than from B0031, whereas previous reports have shown an order of 
magnitude difference between these two RBS options. Flow cytometry for library 
members with strong promoters (Figure 4c) showed that the reason for the unexpected 
low levels of fluorescence from B0034 is a bimodal population of low-expressing and 
high-expressing cells. This population split was ultimately due to mutation of promoters 
in library members with the B0034 RBS due to physiological stress from the high levels 
of protein expression: while measurements of all library members were done from fresh 
transformants from sequence-verified DNA, plasmid sequencing for B0034 library 
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transformants exhibiting these bimodal populations returned multiple competing signals 
indicating that the dual operator sites in R0040 and R0011 had combined to heavily 
mutate the promoter.   
Figure 4d shows that LAA and DAS protein degradation tags can significantly curtail the 
net expression of a gene and that the LAA tag can do so by three orders of magnitude. 
We tagged the C-terminus of eGFP with one of two ssrA tags, the strong 
AANDENYALAA tag or the weaker AANDENYADAS tag. These tags induce sspB-
mediated binding to the ClpX and ClpA proteases, which increases a protein’s 
degradation rate71. The magnitude of the effect of the LAA tag is as much as or greater 
than the impact of using the lowest-efficiency ribosomal binding site. Of note is the 
interaction between expression level and the efficiency of repression via tagging for 
protein degradation. The LAA tag effectively reduces protein levels even for highly-
expressed proteins, whereas the DAS tag is most effective for lowly-expressed proteins 
(giving a reduction of up to 10-fold; for example, B0033 RBS or weak promoters) 
compared to highly-expressed proteins (with reductions typically closer to 2-fold; for 
example, B0031 RBS with a strong promoter). This suggests that overall gene dosage 
may play a role in the effectiveness of post-transcriptional regulation in some cases, 




Figure 4: A library of regulatory elements provides five orders of magnitude of 
control over expression. a) Fluorescence measurements of the library of regulatory 
element combinations. Inset illustrates fluorescence levels at a higher gain setting 
for library members with insufficient fluorescence to be measured accurately at the 
same gain setting as in the main plot. Construct names are the promoter name 
(R0011 & R0040 known strong promoters, J23116 &J23117 known weak 
promoters, and the PznuC and PzntA promoters), followed by an indicator of the 
ribosomal binding site part number (31-34), and then the degradation signal added 
to the protein sequence (no signal, weak DAS signal, or strong LAA signal). Error 
bars represent the standard error of the mean. b) Changing ribosomal binding sites 
for strong or weak promoters provides orders of magnitude reduction in expression. 
Error bars represent the standard error of the mean. c) Flow cytometry plots 
showing increasingly mixed populations for higher-strength (B0034) ribosomal 
binding sites (top) as opposed to weaker ribosomal binding sites (bottom), indicating 
that the bulk fluorescence measured for B0034 RBS under the strong promoters 
used here is an underestimate of the actual per-cell fluorescence for B0034 under 
unaltered promoters. Sequencing of plasmid DNA from cultures with bimodal 
populations yielded mixed traces, indicating mutation of the plasmids to reduce… 
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Figure 4 continued: …fluorescence production. d) Degradation tags can also yield 
orders of magnitude reduction of protein levels; the strong LAA tag typically 
provides two or more orders of magnitude of decrease in fluorescence, while the 
weaker DAS tag is more variable in its reduction of fluorescence. Error bars 
represent standard error of the mean; only positive error is indicated due to the 
logarithmic scale of the plot because the lowest values are near the detection limits 
of the instrument and would include zero in the opposite direction. 
2.3.4 Post-transcriptional control of carotenoid production 
Using this library of regulatory element combinations and the insights gleaned from 
them, we then assembled thirteen targeted carotenoid-expressing constructs to identify 
those that could produce two distinct states: one dominated by lycopene and one 
dominated by β-carotene, which was not observed in our initial attempts. The test 
constructs consisted of (Figure 5a) crtY being driven by the PzntA promoter and zntR 
driven by a weak constitutive promoter. crtEBI was cloned in without an explicit 
promoter (for reasons of severe growth restriction which are discussed and explored in 
Chapter 4) so as to yield very low transcription, consistent with previous work where 
crtEBI had an inducible promoter that was never induced since its expression was 
detrimental to cell growth64. Regulatory elements of crtY were varied to control 
conversion of lycopene to β-carotene.  
To manipulate levels of CrtY, we selected variants from the fluorescence characterization 
presented in Figure 4, as well as additional methods for manipulation of expression 
levels. We varied the RBS of crtY and added the strong (LAA) degradation tag to crtY. 
We did not explore further the strong B0034 RBS since preliminary pilot experiments 
indicated we would need such substantial reduction in expression to allow a lycopene-
dominated state that RBS variation would likely be necessary. We also added another 
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level of control over the amount of gene expression via variation of vectors, employing 
high, medium, low, and essentially-single copy vectors. This would titrate not only the 
total amount of CrtY in the cell from leaky or mildly-induced expression, but also the 
expression of crtEBI, which also may cause toxicity and could prevent greater 
accumulation of carotenoids. 
Changing only the RBS of crtY was insufficient to yield a distinct lycopene state. 
Replacing the original B0034 RBS with the B0033 RBS yielded no visible lycopene in an 
uninduced state (and essentially no measurable lycopene), but a substantial amount of β-
carotene (Figure 5b), despite the B0033 RBS being two to three orders of magnitude 
weaker than the B0034 RBS used in the original construct. (Again, this supports the 
earlier assessment that the reason why no lycopene-only state could be detected was due 
to too much crtY expression at low zinc rather than too much vioABCDE expression at 
high zinc.) Even combining a lower-strength (B0032) RBS with a strong (LAA) 
degradation tag, which should yield four or more orders of magnitude less CrtY, was not 
sufficient to allow lycopene to persist in an uninduced state (Figure 5c). 
When the vector was varied, substantial amounts of lycopene were produced (Figure 5d). 
Medium and low copy number plasmids yielded substantial lycopene at low zinc that is 
repressed at high zinc, and a fosmid yielded such substantial production of lycopene that 
CrtY could not be induced enough to consume it (yielding a single state in the pathway 
dominated only by lycopene instead of by β-carotene). The most promising combinations 
appear to be the medium- and low-copy plasmid with a degradation tag and a moderate 
RBS, yielding a lycopene-dominated state and a β-carotene dominated state, though with  
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Figure 5: Varying regulatory sequences and vector enables a lycopene-dominated 
state and allows manipulation of the concentration at which it disappears. All error 
bars represent the standard error of the mean. All measurements were taken at 0, 
50, 500, or 1000 µM zinc, though an offset has been applied in panel D for 
visualization purposes. a) A simplified version of the construct used to test only 
carotenoid production for a selection of constructs with varied regulatory sequences 
and vectors. Ribosomal binding sites and degradation tags are omitted for 
simplicity. b) Changing only to a very weak ribosomal binding site is insufficient to 
produce a lycopene-only state, and generally insufficient to produce any lycopene at 
all. This suggests that multiple levels of control must be used. c) Using a…       
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Figure 5 continued: …moderate ribosomal binding site and a strong degradation 
tag (LAA) enables the detectable production of lycopene but still does not enable a 
lycopene-dominated state. d) Changing the vector carrying the construct from panel 
C enables the presence of a lycopene-only state. For the lowest-copy plasmid (the 
fosmid), so little CrtY is accumulated even at full zinc induction that only a 
lycopene-dominated state can be observed. The medium-copy 6A1 vector offers two 
distinct states. e) Co-transforming with a plasmid containing the mevalonate 
pathway (pJBEI-MEV) to supplement production of lycopene alters the transition 
point between the lycopene and β-carotene states. At 50 µM Zn2+, the pJBEI-MEV-
supplemented cells have still produced orders of magnitude more lycopene than β-
carotene, while the non-supplemented strain is already transitioning to a β-carotene 
state. Of note is that the lycopene production at no supplemented zinc is three times 
higher in the supplemented strain, as expected. f) Streak of pJBEI-MEV-
supplemented strain from panel E on zinc gradient plates showing a fairly distinct 
transition between states. The cells change from red to orange going left to right. 
Below the plates are two parts of the same image cropped next to each other to 
highlight the color differences. 
 
less switch-like behavior than expected. Similar behaviors were observed in minimal 
medium cultures (Figure 6). Worth noting is that in many constructs, the lycopene and/or 
β-carotene levels decrease at the 1 mM zinc condition. In previous literature, the full 
induction level of PzntA was found to be at 1.1 mM zinc, and E. coli has been shown to be 
capable of normal growth in an excess of 1 mM extracellular zinc. We suspect that the 
additional metabolic stress of the cells from substantial transcription, translation, and 
pigment synthesis, combined with the toxicity of carotenoid operon genes and potential 
interference with zinc homeostasis due to overexpression of native regulators, increases 
the sensitivity of the engineered cells to zinc. Fortunately, this level of zinc is nowhere 




Figure 6: M9 cultures show similar behavior to LB cultures. Panels A through D in 
this figure correspond to panels B through E in Figure 5, showing that the behavior 
of the cells in minimal and rich medium (which includes an expected baseline level 
of zinc) is extremely similar. Error bars all represent the standard error of the 
mean. Measurements were all taken at 0, 5 and 50 µM Zn2+, though in panel C an 
offset has been applied for visualization purposes. A) Changing only to a very weak 
ribosomal binding site is insufficient to produce a lycopene-only state, and generally 
insufficient to produce any lycopene at all. This suggests that multiple levels of 
control must be used. B) Using a moderate ribosomal binding site and a strong 
degradation tag (LAA) enables the detectable production of lycopene but still does 
not enable a lycopene-dominated state. C) Changing the vector carrying the 
construct from panel C enables the presence of a lycopene-only state. For the lowest-
copy plasmid (the fosmid), so little CrtY is accumulated even at full zinc induction 
that only a lycopene-dominated state can be observed. The medium-copy 6A1 vector 
offers two distinct states. D) Co-transforming with a plasmid containing the 
mevalonate pathway (pJBEI-MEV) to supplement production of lycopene alters the 
transition point between the lycopene and β-carotene states. At 50 µM Zn2+, the 
pJBEI-MEV-supplemented cells still have still produced much more lycopene than 
β-carotene, while the non-supplemented strain is already transitioning to a…  
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Figure 6 continued: … ß-carotene state. Of note is that the lycopene production at 
no supplemented zinc is three times higher in the supplemented strain, as expected. 
 
2.3.5 Enhancing lycopene production affects sensor response 
Another alternative to manipulate the apparent response of PzntA-driven expression is to 
stimulate the overall production of lycopene in the cells. The root cause of a β-carotene-
only state is that there is sufficient CrtY to enzymatically act on all of the lycopene that is 
present. To this point, we had primarily explored just approaches designed to decrease 
the levels of CrtY. Instead, we could increase the production of lycopene such that there 
is insufficient CrtY to act on all of the lycopene in the cell. Lycopene production, or more 
generally the production of carotenoids and isoprenoids, has long been a target for 
metabolic engineering studies, with significant advances made in terms of overproducing 
background strains and identification of multiple independent ways to increase carotenoid 
titers. One well-known approach is the introduction of a mevalonate pathway to 
supplement the production of precursors for the carotenoid and isoprenoid pathways64.  
By co-transforming engineered carotenoid constructs with a plasmid containing the 
mevalonate pathway (pJBEI-MEV), we substantially affected the response of the 
carotenoid-producing sensor (Figure 5e). A moderate RBS combined with a strong 
degradation tag and a low-copy plasmid initially yielded a system offering a crossover in 
production from lycopene to β-carotene. At approximately 50 µM of zinc, the levels of 
lycopene and β-carotene were of the same order of magnitude. However, by 
supplementing with pJBEI-MEV, production of lycopene was increased threefold, and at 
50 µM lycopene levels remained much higher than β-carotene levels. This effectively 
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changed the “switching point” between lycopene and β-carotene states in the 
supplemented cells. This behavior was observed both in rich medium and in minimal 
medium. While in this case it moved the switching point perhaps to a level beyond 
physiological relevance, application of this approach with other constructs allows for 
another level of manipulation to engineer the precise response desired. 
2.3.6 Engineered distinct red and orange system states 
Figure 5f demonstrates that a transition between red and orange states is now possible 
after substantial pathway engineering. In order for both states to be possible for the same 
cells, multiple components needed to be precisely controlled in combination. With a 
moderate RBS, a strong degradation tag, and the medium-copy plasmid, levels of CrtY 
were limited at low zinc levels (preventing reaction of lycopene) but were adequately 
inducible to allow a switch to β-carotene at higher zinc levels. Selection of a different 
plasmid in this configuration would have different results: for example, on the fosmid, 
CrtY levels are limited so much that the β-carotene state can never be reached (though for 
other configurations, for example without LAA tags, the fosmid did allow for 
accumulation of CrtY and production of β-carotene). Supplementation of lycopene 
production via the mevalonate pathway enabled further tuning of the zinc levels at which 
that transition occurred. Taken together, these strategies enabled the ultimate within-
pathway state-switching goal of the biosensor. 
2.4 Discussion 
In this chapter, we present the design and engineering of a biosensor capable of 
responding to extracellular levels of a micronutrient, zinc, with potential application to 
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blood test diagnostics. Specifically, the biosensor was designed to produce pigment, 
rather than fluorescence or related readouts, to facilitate equipment-free usage since the 
color of the readout can be assessed with the naked eye. Our initial efforts yielded only a 
two-state sensor, despite the design of the construct to have three distinct regimes of 
pigment production. (A two-color sensor would still be useful, though having a third state 
provides increased zinc status resolution and thus more information for determining when 
and where to perform nutritional interventions.) This prompted the need for metabolic 
engineering of the construct, as baseline levels of the last gene in one pigment production 
pathway prevented the accumulation of an intermediate intended to represent a distinct 
readout state in the device. 
These efforts present advances in a number of different directions within the purview of 
developing metabolically engineered pigment-based biosensors. We integrated two 
different heterologous pigment production pathways, and were able to shut one off 
completely so as to enable the visibility of the other. Our use of natural zinc-responsive 
promoters and transcription factors provided one system (Zur/PznuC) that was appropriate 
for our application, but another system (ZntR/PzntA), with a wide dynamic range and 
excessively high baseline expression when in an uninduced state, required significant 
engineering to be usable in the sensor. Engineering efforts were limited to components 
besides the promoter and regulator themselves, as mutating those would likely have been 
prone to loss of zinc specificity 72 (particularly true given the mechanism of action of 
ZntR). Without promoter engineering as a viable possibility, we focused on post-
transcriptional regulation to harness a very small portion of the dynamic range of the 
system and to sufficiently suppress expression to allow multiple color states within a 
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single pathway. The system started with no switching capability whatsoever, but we were 
able to engineer in switching capability as well as demonstrate our ability to change the 
level at where the switch occurs. This is particularly relevant since our application limits 
us to the small fraction of ZntR’s dynamic range that is physiologically relevant.  
We achieved our goals via a directed, rational approach to synthesizing pigment-
producing constructs, driven by knowledge gained from initial fluorescence 
characterization of regulatory elements. We did this due to the difficulty in high-
throughput screening for our desired phenotype: screening a library of transformants for a 
single color at a single zinc concentration does not provide sufficient information, 
decreasing the potential throughput substantially. Gradient plates as a secondary screen 
are too qualitative and spatially complex, though a replica plating approach on multiple 
zinc concentrations could have been a viable strategy. Ultimately, though, our rational 
approach also provided deeper insight into the requirements for getting the correct level 
of regulation to allow multiple color states in one pathway, which may not have emerged 
from a library screen. 
To sufficiently control the production of our most downstream enzyme in the carotenoid 
production pathway, CrtY, multiple levels of regulation were necessary. Combining the 
use of weaker ribosomal binding sites with protein degradation tags and changing the 
vector allowed for the establishment of inducible color change and tuning of the zinc 
concentration at which the color change occurred. While we observed that the lower copy 
vectors were more effective at allowing a lycopene-dominated state, this phenomenon 
cannot be solely attributed to copy number since vector-specific differences in 
readthrough transcription affect the level of transcription of (promoterless) crtEBI and 
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thus the balance of lycopene and crtY. Nonetheless, our data, along with intuition, 
suggest that copy number likely plays a role in this process; even if not, the fact that 
selection of vector has such a substantial effect on the metabolic phenotype of the cells is 
still an important observation. 
We used fluorescence measurements on a library of regulatory combinations as the basis 
for rational exploration of the design space for production of carotenoids. It is possible 
that the reduction in fluorescence caused by the addition of degradation tags was not just 
due to increased degradation, but caused also by decreased fluorescence per molecule due 
to the tag changing the protein conformation. While this was not something controlled for 
and tempers the interpretations of tag effectiveness from the fluorescence data, the 
carotenoid production results are consistent with our interpretation of the fluorescence 
data on the importance of degradation tags for tuning the behavior of the cells.  
We also note that while the use of native, rather than orthogonal, sensing (zinc-
responsive) elements is not commonplace, it did not prevent successful metabolic 
engineering of the strain. While this aspect of our approach may have led to more non-
linear impacts of the various regulatory changes we implemented due to impacts on host 
cell behavior or impacts of host cell genomic expression, this disadvantage was 
outweighed by the many tools available for genetic manipulation in E. coli and the fact 
that the regulators we used are well-characterized zinc-responsive elements, one of which 
was already known to respond within a physiologically relevant concentration range.  
It is worth noting that these experiments were carried out at a single temperature that is 
not necessarily the same as the physiological temperature of the organisms used as 
 41 
sources for the heterologous pigment biosynethesis pathways. Since it is known that 
enzymatic activities of some of the components we have employed are temperature-
dependent (i.e., enzymes in the violacein pathway66), it is possible that some 
characteristics of our sensor’s behavior may also change as a function of incubation 
temperature. Exploring the temperature dependence of the switching point of our 
construct is an important next step, as the results will have design implications for the 
ultimate implementation of a blood testing device incorporating our sensor. 
The desire for tightly controlled but inducible transcription is not unique to our 
application. For example, there has been recent work developing dynamically controlled 
metabolic engineering, where the genes for target production remain uninduced during 
growth phase to avoid toxicity, or where genes crucial for growth are turned off at a 
specific time to redirect carbon flux towards the production of desired products73-76. 
While one way to achieve this would be through small molecule induction after sufficient 
growth, as might be done for protein expression, there have also been efforts to have 
automated induction upon sufficient accumulation of cells, for example via response to 
phosphate limitation or quorum-sensing molecules77-81. These latter cases are the most 
likely to experience issues similar to the challenges in our biosensor: where the promoter 
selection is driven by the specific needs of the application and is relatively inflexible, 
meaning that control of expression must be exerted through other means. 
2.5 Conclusion 
The sensitivity of metabolic pathways to low levels of enzymatic expression – a key 
aspect of what one could call “precision metabolic engineering” – is not something that 
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has been widely explored in the literature. Nonetheless, it is an extremely important 
aspect to harnessing metabolism for biosensor applications while minimizing the 
transcriptional and metabolic burden on cells (and thus using the same pathway to 
produce multiple different visible outputs). At the outset, we naïvely implemented the 
pigment-based sensor without addressing the underlying metabolic pathway engineering 
problem. It soon became clear that at least some degree of pathway engineering would be 
critical to make a functional reporter that could express two different carotenoids. While 
we initially used pathway engineering to allow a lycopene-only intermediate state to 
persist, we also found that tuning the carotenoid pathway could strongly affect sensor 
response. Adjusting both upstream and downstream pathway expression controlled the 
zinc concentration at which pigment production switched, allowing more control over 
what concentrations would map to ‘intermediate zinc’ and ‘high zinc’ outputs.  
Overall, the most difficult aspect of the engineering task was compensating for leaky 
expression of enzymes downstream of the first pigment indicator. This suggests that 
(when possible) the selection of regulatable promoters with the lowest levels of leakiness 
may outweigh other important factors (e.g., whether it is inducible or repressible, or the 
expected response threshold) when designing future pigment-based sensors. However, for 
natural promoters this will often not be possible, necessitating the precision engineering 
efforts that we have described. Ultimately, multiple levels of control were necessary to 
achieve the desired metabolite production given the limitations in inducible regulation 
and intermediate or product toxicity; we expect that such extensive control will typically 
be necessary in regulating the response of sensors using metabolite reporters. Perhaps the 
most interesting lesson for future strain design was that controlling the levels of 
 43 
precursors for the heterologous biosynthetic pathways can affect the switch point of the 
circuit. This provides a powerful, modular, orthogonal approach to basic pathway 
engineering of heterologous pigment production pathways, and could be considered an 
earlier option in strain design if (as in the mevalonate pathway) there are well-established 
methods to adjust precursor availability to optimize pigment switching around input 
levels of interest from arbitrary sensors.  
The approaches identified and lessons learned could also be generalizable to other 
“precision” applications where extremely selective production of specific molecules is 
critical, including the design of multifunctional (potentially portable) microbial cell 
factories that can produce different products in response to different environmental 
conditions. A key result of this work is that significant, combinatorial regulation was 
necessary in order to limit the immediate production of β-carotene in our construct; while 
it was unsurprising that pigments from two different heterologous pathways could be 
combined via a switch for a visible output, the level of control necessary to prevent the 
reaction of all lycopene to β-carotene was unexpected. While the level of control 
necessary would ultimately be dependent upon enzyme turnover number rate, knowledge 
that such levels would need to be so precisely regulated for pathway control will likely 
play a key role in other precision metabolic engineering applications in the future. 
 
 44 
CHAPTER 3. IMPLEMENTATION OF A THREE COLOR ZINC 
SENSOR 
3.1 Introduction 
The previous chapter detailed our initial efforts to tune the output of PzntA such that the 
two colored molecules from the carotenoid pathway would be available to us as output 
states for our sensor. This was done using standard techniques like altering RBS 
efficiency, controlling overall gene dosage with plasmids of differing copy number, and 
altering protein half-life through use of ssrA degradation tags, as well as the novel 
approach (at least from a synthetic biology perspective) of tuning sensor output 
independent of the sensory components by altering the availability of the native 
metabolic precursors to the carotenoid pathway, IPP and DMAPP. While we 
demonstrated the ability to tune performance of the carotenoid pathway to alter the 
behavior of pigment production in response to zinc, that work did not go so far as to 
successfully tune the response over a physiologically relevant concentration of zinc for a 
human serum zinc assay. Additionally, while we showed the proof-of-concept three color 
strain which led us to a detailed investigation of transcriptional, translational, post-
translational, and metabolic strategies to control when different carotenoids are produced, 
we did not discuss any tuning of PznuC and the other pigment used as a reporter, violacein. 
In this chapter, we expand upon the work presented in Chapter 2 by varying expression of 
both regulators, ZntR and Zur, with the goal of enabling the transition between 
pigmented states between lycopene and ß-carotene within a reasonable concentration 
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range of zinc that would be present in human serum. We also present the tuning of PznuC 
and violacein expression by altering the ability of Zur to bind PznuC by introducing decoy 
operator sites for Zur, as well as the creation of an inverter for PzntA by using it to control 
the expression of Zur, thus allowing increases in transcription from PzntA in response to 
increases in zinc to map to a decrease in transcription from PznuC. Finally, we investigate 
growth of E. coli and sensor response in cultures with varying amounts of normal human 
serum (NHS) and serum preprocessed by heat shock and/or removal of zinc with a 
chelating resin to simulate zinc deficiency. 
3.2 Results and discussion 
3.2.1 Dynamic range of promoter regulator pairs 
In initial efforts, we identified that the expression levels of the zinc-responsive regulators 
ZntR and Zur can have a major impact on the dynamic range of the reporters that they 
regulate (data not shown). Since a requisite step in our efforts is the precise engineering 
of metabolic state to enable production of (hopefully) only one pigment at a time82, a high 
degree of dynamic range would enable a transition between repressed or uninduced levels 
of a pigment that are not visually detectable and induced levels that are obvious to the 
naked eye in a reasonable amount of time. We thus first sought to characterize the 
dynamic ranges of the two regulator/promoter systems at varying expression levels of the 
regulators. 
To identify regulator expression levels that maximize the range of transcription rates 
available over a physiologically relevant concentration range of zinc, a series of 
fluorescent reporter plasmids was constructed consisting of transcriptionally insulated  
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Figure 7: (a) Schematic of envisioned test implementation. Patient blood is collected 
in the field, separated using field-friendly approaches, and combined with packaged 
sensor cells. The cells grow and produce pigment indicative of subject micronutrient 
status. (b) Schematic of regulator test construct. The promoters and ribosomal 
binding sites (boxed) for zinc-responsive regulators ZntR and Zur were varied to 
determine optimal expression for improved dynamic range over physiologically 
relevant zinc concentrations. (c) Fluorescent reporter output demonstrating sensor 
dynamic range from 0 to 20 µM Zn2+ with different expression levels for ZntR and 
Zur. Regulator pairs one and two (arrows) were used in subsequent two and three 
color pigment biosensors. Error bars indicate standard deviation. 
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PzntA and PznuC controlling expression of mRFP and eGFP. The regulators ZntR and Zur 
were constitutively expressed with different combinations of promoters and ribosomal 
binding sites (Figure 7b). These plasmids were transformed into E. coli and grown in 
minimal media with and without treatment by Chelex 100, a zinc-selective chelating 
resin, each with and without 20 µM supplemented ZnSO4. Fluorescent output of both 
reporters was measured and compared to determine promoter performance over this 
range of zinc. The dynamic ranges of both promoter/regulator systems are plotted against 
each other in Figure 7c. The two highest dynamic range regulator pairs (referred to 
hereafter as Pair 1 and Pair 2) were selected for subsequent experiments with two- and 
three-pigment output sensors. 
These efforts yielded some straightforward results as well as others that were not quite as 
expected. Unsurprisingly, most of the best performance was observed in the resin-treated 
media; both regulator systems already exhibit some degree of response (induction or 
repression) starting at low micromolar levels of zinc or below, so the trace levels of zinc 
present in untreated medium would cause the unsupplemented medium to yield lower 
dynamic ranges. Interestingly, the highest dynamic ranges do not correspond in rank 
simply to the highest expected expression of regulators estimated by combining the 
relative translation rate predicted by RBS Calculator83 and the previously-characterized 
relative transcriptional output of constitutive promoters (Table 2, Table 3). For example, 
in normal media for PzntA, lower dynamic range over 20 µM was observed in 3-4 3-4 than 
in 2-4 7-1, even though the promoter controlling ZntR is exceptionally weak. A possible 
explanation for this behavior is that the two regulators have different affinities for zinc 
and are both competing for zinc from the same pool36,84. Overexpression of these zinc-
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binding proteins likely affects the natural partitioning of zinc ions throughout the 
proteome. As a result, a change in expression of Zur could, for example, alter the 
availability of zinc for ZntR and thus change PzntA transcriptional output for a given  
 
Table 2: Rank order list of top six fluorescent reporter dynamic ranges of 0-20 µM 




























7-1c 480364 429402.1 235.0797 
7-4  
7-1c 480364 429402.1 
168.3276 
7-4  
7-1 480364 429402.1 153.4526 
3-4  
3-4 c 334146.1 55663.23 
147.7143 
3-4  
3-4c 334146.1 55663.23 146.4823 
2-4  
7-1c 480364 2650.63 
142.8567 
2-4  
7-1c 480364 2650.63 101.292 
7-4  
7-1 480364 429402.1 
95.211 
2-4  
7-1 480364 2650.63 77.5182 
2-4  
7-1 480364 2650.63 
93.86331 
3-4  
3-4 334146.1 55663.23 74.88951 
3-4  
3-4 334146.1 55663.23 
 
Table 3: Output from the RBS Calculator and relative transcriptional strength of 







31zur 2965.21 112 1 
32zur 5074.87 113 21 
33zur 353.89 117 162 
34zur 15911.72   
34zntr 2650.63   
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concentration of zinc. 
The behavior between media with and without treatment by Chelex between regulator 
pairs is also noteworthy. For Zur/PznuC, the three arrangements exhibiting maximum 
dynamic range were all in Chelex-treated media, and the next three were the same 
constructs in untreated media. The relative rank order of 3-4 3-4 and 2-4 7-1 is reversed 
in untreated vs treated media, however the results in both cases are close enough that the 
differences are not significant. For PzntA/ZntR, the top two performers were 7-4 7-1 in 
each media type. It is interesting to note that nearly all of the top PzntA/ZntR candidates 
seem to correspond more with expected Zur expression than expected ZntR expression. 
This is consistent with increased levels of Zur outcompeting ZntR for zinc at low zinc 
concentrations, suppressing output from PzntA 
3.2.2 Two-color and three-color pigment sensors 
Using regulator levels from Pair 1 and Pair 2 from above, a library of pigment-based 
reporters was constructed with varying ribosomal binding strength and an LAA protein 
degradation tag71 on crtY, the gene that converts lycopene to β-carotene. (When plasmids 
are described here, they are identified by regulator pair and RBS on crtY, with an ‘L’ 
denoting the presence of a degradation tag on crtY – for example, Pair 1 33 or Pair 2 
33L.) The lycopene operon from Pantoea ananatis, crtEBI, was constitutively expressed 
from a weak promoter. The library was grown at 0, 10, 20, and 100 µM zinc in minimal 
media for twenty four hours and carotenoids were extracted for HPLC analysis.  
Figure 8a shows four representative library members demonstrating a variety of behavior 
over the tested zinc concentrations. First, at the two extrema, sensors were produced that 
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were unable to appreciably respond to changes in zinc. In one case, the only accessible 
state at all tested zinc concentrations was β-carotene. This is a challenge in using two 
consecutive pigments in a metabolic pathway as reporters: tight control of downstream 
enzymes is necessary to maintain a color output of an intermediate metabolite, problems 
we previously found could be addressed by adjusting precursor availability54. This 
indicates that even with superior dynamic range from Regulator Pair 1, leaky 
transcription from PzntA is still sufficient to prevent access to a lycopene-only state with a 
weak ribosomal binding site alone. At the other extreme, adding a degradation tag to crtY 
in concert with a weak ribosomal binding site is sufficient to prevent access to the β-
carotene state. In between, stronger ribosomal binding sites coupled with a LAA 
degradation tag shift the switch point from between 0 and 10 µM Zn2+ (32L) to between 
20 and 100 µM Zn2+ (34L), demonstrating that with these regulator pairs, precursor 
supplementation is not strictly necessary to switch states in the carotenoid pathway at 
these zinc levels. Nevertheless, altering precursor availability remains a viable option for 
tuning a biosensor based on pigmented metabolites. 
Based on a significant difference in fluorescent reporter output, it seemed likely that 
switching between regulator pairs one and two would also allow fine tuning of pigment 
control over the concentration range tested; however, two different pigment reporter 
constructs (32L and 34L) exhibited little to no change based on the regulator pair with 
which they were coupled (Figure 8b). In the case of 34L, no significant differences 
between the two regulator pairs were observed in lycopene and β-carotene measurements 
at any concentration range, including 10 and 20 µM Zn2+ at which there were 
intermediate amounts of both pigments. The 32L construct had significant differences in  
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Figure 8: (a) Representative output of two-color biosensors showing two extreme 
cases in which sensor output does not switch (left, right) and two intermediate cases 
demonstrating a shift in concentration of zinc at which sensor switches from 
lycopene to β-carotene (middle). (b) Carotenoid output comparing regulator pairs. 
While a substantial difference between regulator pairs was observed with 
fluorescent reporters (Figure 7c), two different pigment reporters (32L and 34L) 
show different lycopene production behavior in response to zinc but little difference 
in carotenoid production as a function of regulator pair. Error bars indicate 
standard deviation. 
 
behavior of the two regulator pairs only at 100 µM, and only in the total amount of β-
carotene produced as no lycopene was detected in either strain. This suggests that the 
response of the carotenoid pigment reporter is relatively robust to regulator expression 
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levels. This was somewhat surprising, as we had previously observed that similar reporter 
constructs with genomic regulators alone or with genomic regulator operons co-expressed 
on the reporter plasmid were unable to switch state between lycopene and β-carotene. 
With the carotenoid reporter functioning over the desired concentration range, the second 
zinc-responsive promoter, PznuC, was added to the sensor to control expression of the vio 
operon that produces the pigment violacein. This resulted in a strain that produced three 
distinct color states over a 20 µM Zn2+ concentration range (Figure 9a). At 0 and 0.1 µM 
Zn2+, PznuC was derepressed and higher quantities of violacein were produced. At 0.5 and 
1 µM Zn2+, the sensor output was dominated by lycopene production. An intermediate 
state in which both lycopene and β-carotene were present in appreciable quantities was 
observed at 5 and 10 µM zinc, but by 20 µM zinc, the sensor output was dominated by β-
carotene. The strategy in using these pigments was to tune violacein production to 
visually overpower lycopene in low zinc states such that the cells would appear purple 
even though lycopene was still present. In this construct, violacein production was not 
high enough at low zinc concentrations to produce a cell pellet in which only violacein 
was visibly detectable (Figure 9b); however, there remained a clear difference in pellet 
coloration between the high violacein states at low zinc and all other conditions. 
Additionally, though measured levels of both lycopene and β-carotene were intermediate 
at 5 and 10 µM zinc, there was little observable difference between the cell pellets at 
these conditions and those at 20 µM, at which essentially only β-carotene was detected in 
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Figure 9: (a) Demonstration of a three-color sensor. At very low zinc, the cells 
produce substantial violacein and lycopene. At increasing concentrations of zinc, 
violacein production is repressed and the sensor is in a primarily lycopene state. As 
zinc increases further, lycopene is consumed and cells enter a primarily β-carotene 
state. (b) Cell pellets from the experiment in panel a. (c) Fluorescent reporter output 
in decoy Zur operator test. Asterisks indicate significance at p<0.05. (d) Violacein 
extract levels from decoy Zur operator test and varying RBS strength on inducible 
Zur. A construct without a decoy array or inducible Zur is presented for 
comparison (blue). Double asterisks denote statistical significance (p<0.05) between 
red and blue. Single asterisks denote statistical significance between grey and blue 
(p<0.05). Error bars indicate standard deviation. 
 
appreciable quantities in extractions. The result of this is three distinct color states 
between 0 and 20 µM Zn2+. 
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Replicates two and three with no supplemented zinc displayed some inhomogeneity in 
pigment production and formed a striated pellet in which cells with low or no violacein 
production formed the base of the pellet, making violacein difficult to detect visually 
(Figure 9b). Similar behavior was not observed at 0.1 µM. This behavior was not 
apparent in the extracts, as no substantial difference in normalized violacein production 
was measured at the two lowest zinc conditions (Figure 9a). 
3.2.3 Tuning PznuC response with decoy operators 
Unfortunately, the concentration range at which violacein production becomes visually 
undetectable in the construct depicted in Figure 9a,b (less than 1 µM) is far below 
medically relevant levels in human serum. To address this issue, we explored the use of 
additional “decoy” binding sites to sequester zinc-bound Zur and thus increase the zinc 
concentration necessary to yield sufficient zinc-bound Zur to repress express of the 
violacein operon. We introduced to the plasmid an array of eight decoy binding sites for 
Zur comprising a combination of PZinT85 operators and completely palindromic PznuC 
operators. On a fluorescent reporter construct for PzntA and PznuC with no additional 
regulator expression (only genomic expression), the decoy array had the effect of 
significantly increasing the levels of the fluorescent reporter under full zinc repression, 
but did not significantly alter (Figure 10) the zinc concentration at which expression first 
became unobservable.  
In an attempt to rectify this, the number of decoy binding sites was increased to thirty two 
and zur was placed under the control of PzntA with either a weak (33) or intermediate 
strength (31) ribosomal binding site (Figure 9c), forming an inverter for PzntA Induction 
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from 0-20 µM produced higher PznuC output in the reporter with the weaker RBS for Zur 
compared to the stronger RBS at all zinc concentrations, though these differences were 
only significant (p<0.05) at 0.1 and 5 µM Zn2+. This is consistent with the hypothesis that 
driving expression of Zur from PzntA yields insufficient Zur at low zinc concentrations to 
saturate the decoy array and PznuC. As transcription from PzntA increases with Zn2+ 
concentration, additional Zur is produced, further repressing PznuC (though with the 
weaker RBS, there is still insufficient Zur to fully repress fluorescence). PzntA output was 
also increased significantly at all concentrations except 0, 0.1, and 5 µM Zn2+ (p<0.05). 
The interpretation of this is less straightforward, but a possibility is that for any given 
concentration of zinc, there should be less Zur expressed from plasmids with the weaker 
RBS and thus fewer molecules to compete with constant ZntR levels for zinc binding. 
Though this strategy no longer relies directly on the natural dynamics of zinc binding to 
Zur to regulate PznuC, these results demonstrate that the simple inverter and decoy array 
are effective at shifting the apparent concentration at which expression from PznuC is 
repressed from about 0.3 µM (no decoys and Regulator Pair 1, data not shown), to 
between 1 and 5 µM (32 decoys with strong RBS on Zur), to greater than 20 µM (32 
decoys and weak RBS on Zur). This suggests that the threshold between sensor color 
output for a given strain can be effectively tuned based on the final needs of the sensor 




Figure 10: Effect of decoy Zur operators on the output of PznuC. The unregulated 
reporter (red) has substantially lower expression in the repressed state than the 
construct with an 8x decoy array (grey). This is rectified upon zinc-dependent 
expression of Zur (purple). Error bars represent standard deviation. 
 
The same changes were made to the pigment reporter construct. Violacein extractions 
(Figure 9d) and cell pellets (Figure 11) both show trends similar to those seen with the 
fluorescent reporter. The violacein content of strains with the stronger RBS on zur was 
significantly higher at all zinc concentrations above zero and the weaker RBS was 
significant at all conditions except 5 and 20 µM Zn2+ (while the trends were consistent, 
increased variability brought the differences below p < 0.05). Though the strain harboring 
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the weaker RBS had more violacein on average, the difference between the two decoy 
strains was not statistically significant at any concentration of zinc. These results 
demonstrate that behavior of the decoy array and inverter is replicated using pigments, 
meaning that the concentrations at which violacein becomes undetectable and thus the 
sensor color output changes can be effectively tuned using this approach. 
A likely source of variance in the violacein measurements is instability in the decoy 
array. We observed significant loss of violacein pigmentation in biological replicates 
during some experiments and suspected that the decoy array might be altered in cultures 
exhibiting that behavior due to the number and proximity of repeated nucleotide 
sequences in the decoy array and the high cellular strain of enzyme expression. To assess 
this, plasmid DNA from a sample of the cultures was amplified using PCR, showing 
significant deviations from the expected band length (Figure 12) and frequently revealing 
an assortment of decoy array lengths. Though the presence of repeated sequences on a 
plasmid might be inherently unstable, we note that we only observed this phenomenon in 
plasmids using pigments as reporters. Since loss of decoy sites would significantly reduce 
expression of the vio operon, this observation suggests that violacein expression is a 
significant burden on cells and such deletions are probably selected for evolutionarily, 
putting practical limits on the number of decoy sites possible in arrays.  
3.2.4 Growth and testing in serum 
Ultimately, the application of a field-deployable biosensor will require the direct 
measurement of a common biofluid. For zinc, this necessitates biosensor growth and/or 
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response in human serum or plasma. One of the prevailing recommendations for 
evaluating zinc status is plasma zinc86 ,but to facilitate development, we chose to use 
 
 
Figure 11: Cell pellets from the violacein extraction experiment described in Figure 
9d. Note lower pigmentation at higher zinc with intermediate strength RBS. 
 
pooled commercial off-the-clot serum to avoid any potential interference from coagulants 
or anticoagulants. While there is a potential discrepancy between serum and plasma zinc 
levels, this is solely due to how the fluids are commonly handled prior to analysis, and 
choosing serum zinc allowed us to evaluate the sensor in a similar matrix to what would 
be expected in the field86. To simulate zinc deficiency, the serum was treated with Chelex 








   













Regulator effects on 32x decoy with pigment
Control
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100 resin to remove zinc, allowing retitration to measure the response of the sensor at 
various concentrations of zinc. 
 
 
Figure 12: Characteristic banding pattern of CPCR of cells taken from a 32x decoy 
pigment induction experiment. The expected banding pattern for an intact decoy 
array is 1.4 kb. Other bands indicate an inhomogeneous population with varying 
band length. Each box indicates biological replicates run in triplicate. 
 
In initial experiments, cultures were inoculated with small volumes of resuspended 
colonies from agar plates. We grew these in mixtures of serum and media with increasing 
percentages of serum, but were unable to grow cultures in even our lowest (10%) 
serumconcentration (data not shown). This interference with bacterial growth may have 
been due to the passive immune functionality present in human serum in the form of the 
complement system87, a cascade of proteins with the ability to form pores in foreign cell 
membranes, ultimately causing lysis. 
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Figure 13: (a) Growth of DH10B in decreasing concentrations of normal human 
serum, heat-inactivated human serum, and fetal bovine serum. Normal human 
serum cultures failed to grow at all concentrations above 0.1%. Asterisks indicate 
differences at p < 0.05. (b) Fluorescent reporter demonstrating sensor response in 
heat-inactivated human serum treated with Chelex 100 resin. At 5% serum, 
differences were significant between cultures with and without zinc supplementation 
for both PznuC and PzntA (** p<0.01, * p<0.05). Zinc supplemented as if serum had 10 
µM zinc. (c) NHS titration in M9 (* p<0.05). (d) Large-inoculum test of fluorescent 
reporter in human serum (* p<0.05). Zinc supplemented as if serum had 5 µM zinc. 
Only selected important statistical comparisons are presented. Error bars indicate 
standard deviation. 
 
To test if complement system protein activity in serum was interfering with growth, we 
compared cultures with low percentages of normal human serum (NHS), heat-inactivated 
normal human serum (HI NHS), and fetal bovine serum (FBS) that had not been heat-
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inactivated. Heat inactivation should render the complement system inactive and prevent 
lysis of the biosensor and, while FBS should have some form of a complement system, it 
should have lower levels of complement than adult serum88 . DH10B grew robustly in all 
tested concentrations below 10% in both HI NHS and FBS but only at 0.1% NHS (Figure 
13a), suggesting that the complement system interferes with cell growth. Achieving 
consistent and inexpensive heat inactivation in the field poses significant challenges, so 
we investigated alternative methods of achieving growth in NHS. 
To test sensor response, we compared our fluorescent reporter in HI NHS, Chelex-treated 
HI NHS, and zinc-supplemented resin-treated HI NHS (Figure 13b). We achieved robust 
growth up to 10% serum in all conditions, but none at 50% serum. The difference in 
fluorescent reporter output was statistically significant (p<.05) between Chelex-treated 
and 10 µM supplemented Chelex-treated serum at 5% for PznuC and at both 5% and 10% 
for PzntA, indicating that both promoter/regulator pairs could detect changes in a 
physiologically relevant zinc concentration in low-percentage serum media. The lack of 
significant difference in PznuC output observed with and without the addition of zinc could 
be due to an incomplete removal of zinc by the commercial resin. PznuC and Zur respond 
below 0.5 µM in minimal media, and a small amount of zinc remaining in serum could 
cause the discrepancy between 5% and 10% serum media. While a standard protocol was 
used for heat inactivation, it is likely that the complement system was not completely 
inactivated in these experiments, as growth was observed in higher percentage serum in 
subsequent experiments. 
Since growth was observed in initial serum experiments at 0.1%, we asked at what 
percentage serum does growth become significantly reduced and if that was dependent on 
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the initial inoculum. Titrating serum down in 0.1% increments from 1%, we saw 
significant growth below 0.7% NHS (Figure 13c) with significantly increased growth 
relative to no serum at 0.2% and 0.1%. Additionally, a 10-fold increase in inoculum 
achieved growth in 1% serum, suggesting that it may be possible to simply overwhelm 
the complement system with a sufficient bacterial inoculum. 
To further investigate the potential for using high inoculation density to overcome growth 
limitations due to the complement system, overnight cultures were grown, pelleted, and 
concentrated in small volumes of media (OD600: 68). Different volumes of the 
resuspension were inoculated in 96-well plates in 100% and 50% normal human serum in 
M9 media. After incubation for 24 hours, there was a clear cutoff between a starting 
OD600 of 0.227 (0.5 µL inoculum) and 0.0612 (0.135 µL inoculum) in 50% NHS (Figure 
14). Only higher inoculum volumes were used in 100% NHS, and all conditions had 
positive changes in OD600; however, optical density changes were significantly lower in 
100% serum compared to 50%. 
It is important to note that most optical density measurements reported here are actually 
changes in OD600 after culture. Viable cell counts were not measured in most 
experiments; however, to assess whether change in OD600 was a useful indicator of 
growth, CFU counts were assessed on a 50% by volume NHS culture with a high, 
positive change in optical density (+0.667) and a 100% serum culture with a low, 
negative change in optical density (-0.095).  The 50% NHS culture was initially 
inoculated to 4.6x106 CFUs/mL. After overnight incubation, the 50% NHS culture was 
serially diluted and plated and found to have had 3.75x108 CFUs/mL, an increase of 
approximately two orders of magnitude. Conversely, the 100% NHS culture was 
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inoculated to 1.13x108 CFUs/mL. After overnight incubation, the 100% serum culture 
was measured to contain 3.86x106 CFUs/mL, a reduction of approximately two orders of 
magnitude. This suggests that positive increases in optical density in serum experiments 
are in fact due to expansion of bacterial cells. Additionally, decreases in optical density 
appear to be due to significant reductions in viable cells, but with a significantly lower 
absolute change in optical density relative to growth. This can be reasonably explained by 
lysis of cells resulting in roughly cell-shaped debris which still significantly increases 
turbidity, though less than a whole, live cell. 
To determine appropriate serum conditions to test response of the biosensor, the 
fluorescent reporter was inoculated in 75%, 50%, and 25% NHS and Chelex-treated NHS 
with and without supplemented zinc (Figure 13d). The fluorescent readings of PzntA could 
differentiate between NHS and Chelex-treated NHS with and without zinc at 75% and 
50% serum by volume (p<0.05), but differences did not meet the cutoff for significance 
at 25% (p=0.0557 and p=0.0544, respectively). Since zinc is supplemented as if the 
serum contained 5 µM zinc, it is possible that the net 1.25 µM difference in culture 
concentration is below the resolution of this sensor/regulator pair. Results for PznuC 
fluorescent output were inverted, with detectable differences between NHS and treated 
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Figure 14: Overnight changes in OD in 100% and 50% serum in plates with volume 
of OD600:68 feeder culture. Error bars represent standard deviation. 
 
NHS and between treated with and without zinc supplementation at 25% only (p<0.05). 
As the most significant challenge with the three color pigment system is sufficiently 
precise tuning of the highly zinc sensitive Zur/PznuC, 25% serum was used to test the 
sensor response in human serum. A starter culture with pigment reporter plasmid 
harboring a 32x Zur operator decoy array and an intermediate strength RBS on zur was 
concentrated as above, inoculated at a starting OD600 of 0.325, and grown for 24 hours in 
25% NHS and Chelex-treated serum with varying levels of zinc supplementation. 
Extracts (Figure 15A) and cell pellets (Figure 15b) demonstrate a high violacein and 
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between lycopene and β-carotene and decreasing expression of violacein, showing the 
sensor in transition between carotenoid states. Violacein production is substantial in all 
conditions except for untreated NHS. Since pooled commercial NHS should contain 
healthy zinc levels, these results clearly indicate that more tuning of the carotenoid 
transition point will be necessary (which we have previously demonstrated54); however, it 
is extremely promising that violacein production has dropped to a level such that it is not 
visible in cell pellets at healthy zinc levels (Figure 15B, left). 
Notably, violacein production is significantly higher at low zinc conditions in 25% serum 
than in M9 alone (Figure 9d) and a large fraction of violacein is found in the supernatant 
of serum cultures. This could due to metabolic changes in E. coli induced by human 
serum. Another explanation is that since violacein preferentially partitions into the media 
when serum is present, intracellular levels of violacein are kept lower in serum cultures 
than in M9 alone. Removal of product from the cells could help pull on the metabolic 
pathway. Supernatants from M9 cultures show no visible violacein retention, though 
small differences in absorbance are detectable between butanol extractions of supernatant 
from cultures with cells harboring different amounts of violacein. Cell pellets from M9 
cultures were observed to contain more violacein than those in 25% serum, even as total 
violacein production in serum cultures was significantly greater as assessed by 
measurement of violacein in the supernatant (Figure 16). 
3.3 Conclusion 
In summary, we have demonstrated a proof of concept whole-cell biosensor that produces 
outputs detectable and interpretable by the naked eye at physiologically relevant zinc  
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Figure 15: Three color output in serum. (a) Extract from biosensor culture in 25% 
NHS. Chelex serum exhibits the violacein dominated low zinc output. NHS is 
characteristic of output in a healthy individual. (b) Cell pellets from 1 mL of 24 hour 
culture of biosensor in 25% serum. Zinc supplementation levels were selected to 
mimic NHS. Here, NHS (left) shows characteristic pigment output of sensor in the 
presence of healthy zinc levels from commercial pooled serum. Chelex 100-treated 
serum (right) shows pigment output characteristic of low zinc to intermediate zinc 
states. 
 
levels in 25% human serum. By optimizing expression levels of regulators for improved 
dynamic range of PzntA/ZntR and PznuC/Zur between 0-20 µM Zn2+, we demonstrated the 
ability to tune the sensor output between the carotenoids lycopene and β-carotene to 
indicate borderline and healthy zinc levels. A strategy to adjust the response of PznuC, 
initially occurring at non-physiologically low concentrations of zinc, was demonstrated 
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Figure 16: Comparison of images of cell pellets (left) and culture supernatants 
(right) from three color experiments in 25% serum versus M9 alone. Note the 
presence of substantial violacein in 25% serum supernatant, even as cell pellets 
from M9 alone demonstrate comparatively more violacein in cell pellets without 
visible presence in supernatant. 
 
using arrays of decoy binding sites for Zur and using PzntA output to control Zur, fully 
repressing it at zinc levels found in healthy serum and allowing violacein expression at 
levels expected to be physiologically relevant. Complement system interference with 
sensor cell growth in human serum was overcome via high-density inoculations, and a 
proof-of-concept test of a three color sensor was presented. The final transition thresholds 
between purple, red, and orange will ultimately need to be tuned based on the final form 
Minimal media




factor and assay protocol (e.g., percentage serum) of a field-friendly packaged and 
preserved device (which is the subject of ongoing efforts); the proof-of-principle 
presented here for both the sensor and the ability to tune those transition thresholds 
suggests that those goals will be readily achievable using the tools and approaches 
demonstrated here.  
3.4 Materials and methods 
Plasmids and oligonucleotides 
Plasmids and primers from this work appear in Supplementary Tables. Oligonucleotide 
synthesis and sequence verification of all constructed plasmids were performed by 
Operon. 
Molecular biology  
All enzymes were purchased from New England Biolabs. PCR amplification was 
performed with Q5 polymerase. Plasmids were constructed with standard restriction 
endonuclease cloning or Gibson assembly69. All experiments used the E. coli strain 
DH10B. For routine cloning, cultures were grown in LB supplemented as necessary with 
chloramphenicol, tetracycline HCl, and kanamycin sulfate at final concentrations of 33 
µg/mL, 15 µg/mL and 50 µg/mL, respectively. Plasmid purification was performed with 
(Omega) kits. Purification of PCR products was performed with Qiagen kits. 
Zur decoy array construction 
To construct the array of decoy Zur operators, oligonucleotides were synthesized 
containing portions of a modified palindrome and the Zur operator site in PZinT and 
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appropriate restriction sites with sufficient overlapping sequneces. These 
oligonucleotides were mixed and extended with Q5 polymerase (New England Biolabs) 
to create double stranded DNA, which was purified with a Qiaquick PCR purification kit 
(Qiagen), digested, and cloned into vectors to convert them to standard BioBrick format. 
These were then serially cloned to produce the 8x and 32x decoy arrays. 
Violacein extraction 
1 mL of culture was centrifuged for five minutes at 17,900 rcf. The supernatant was 
decanted, 50 µL of deionized water was added, and the pellets were vortexed for five 
minutes in a VWR VX-2500 multi-tube vortexer on the maximum speed setting. 250 µL 
of water-saturated butanol was added and tubes were vortexed for an additional five 
minutes. Butanol suspensions were centrifuged for five minutes at 17,900 rcf and the 
organic phase was transferred to fresh tubes and centrifuged again. The supernatant was 
transferred into microcuvettes and measured in a Genesys 20 spectrophotometer for 
absorbance at 571 nm using water-saturated butanol as a blank. For serum cultures and 
select M9 cultures, an additional measurement of the supernatant was taken for 
absorbance at 571 nm. 
Acetone extraction 
Cultures were centrifuged and resuspended as above, then mixed with 800 µL of acetone 
at 50C to which 1 µg/mL Sudan I had been added as an internal standard. Tubes were 
agitated regularly for 10 minutes, and then centrifuged at 17,900 rcf for five minutes. 450 
µL of the extract was transferred to autosampler vials for HPLC analysis. Vials were 
stored at -80°C until analysis for no more than 24 hours.  
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Carotenoid analysis 
HPLC analysis was performed on a Shimadzu Prominence UFLC with a UV-Vis 
detector. Separation was done on an Agilent Zorbax Extend-C18 Analytical 4.6x50mm 5-
micron column. Mobile phase composition was 50/30/20 
methanol/acetonitrile/isopropanol at a flow rate of 1 mL/min. Peaks were identified by 
comparison with standards purchased from Sigma (Lycopene, ≥90%) and TCI America 
(ß carotene, 97%). Reported carotenoid levels were calculated from the ratios of 
carotenoid peak areas with Sudan I peak areas normalized by the OD600 of the source 
culture. 
Chelex 100 treatment 
When indicated, materials were treated with pH-corrected Chelex 100 resin (Bio-rad) 
using a batch protocol. All steps were carried out according to the manufacturer’s 
protocols. Following treatment with Chelex resin, media were filter sterilized with 0.2 
micron filters. 
Modified M9 media 
A modified minimal medium similar to M9 except with organic phosphate to allow zinc 
titration was used for all experiments in minimal medium. A 5x salt solution was made 
containing 10 g/L ß-glycerophosphate, 8.2 g/L KCl, 22.5 g/L NaCl, 5 g/L NH4Cl, and 
19.5 g/L MES which was adjusted to pH 7.4. The salt solution was combined with 1.92g 
SC-ura amino acid mixture (Sunrise Science), 2 mL 1M MgSO4, 100 µL CaCl2, 5 mL 
80% glycerol, 10 mL 20% glucose, and 10 mL 1% Thiamine HCl, diluted to a final 
volume of 1L, and filter sterilized. 
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Cell culture 
All cultures were inoculated from freshly transformed DH10B colonies. For minimal 
media and small-inoculum serum experiments, colonies were resuspended in 52 µL of 
M9. 5 mL cultures were inoculated with 3 µL of these resuspensions. For large-inoculum 
serum experiments, six 8 mL overnight feeder cultures were grown in M9 with 1 µM 
supplemented ZnSO4 and resuspended in a volume of 400 µL of M9. The optical density 
of a serial dilution of the resuspension was used to determine inoculum volumes. Cultures 
were grown aerobically for 24 hours at 37°C. For fluorescence experiments, optical 
density measurements and fluorescence readings were taken on a Synergy H4 (Biotek) 
plate reader using 150 µL aliquots of cultures in 96-well plates. 
Estimation of relative protein expression 
The relative transcriptional strength of the constitutive reporters was taken from the 
registry of standard biological parts. The RBS efficiency was calculated with RBScalc83. 
These two numbers were multiplied to approximate expected relative protein expression 
(Table 2). The naming convention used lists promoter-ribosomal binding site for ZntR 
and then promoter-ribosomal binding site for Zur. For example, 7-4 7-1 denotes a 
construct with J23117 B0034 ZntR and J23117 B0031 Zur. ‘c’ denotes the results were 
from Chelex-treated media. 
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CHAPTER 4. INVESTIGATING GROWTH RESTRICTION IN 
THE CAROTENOID PATHWAY 
4.1 Introduction 
The carotenoid pathway has been the target of extensive metabolic engineering efforts, 
aimed both towards lycopene itself as a valuable product, and as a reporter to 
demonstrate increased flux through engineered mevalonate or DXP pathways which 
produce the precursors to the bacterial carotenoid pathway (isopentenyl pyrophosphate 
and dimethylallyl pyrophosphate). Typically, the genes used efforts in E. coli are from 
Pantoea ananatis89 or Pantoea agglomerans47,48,64. Many efforts in metabolic 
engineering in E. coli have involved expression of genomic fragments containing the 
carotenoid genes, meaning the genes possessed wild-type RBSs and promoters. The 
genomic coding sequences for crtIB overlap in P. agglomerans, and even when genes 
were separated, this operon was often kept as a single, intact fragment. Additionally, 
some of these efforts noted that induction of the cloned fragments caused extreme 
disparities in cell growth48, so many metabolic engineering efforts were carried out in the 
absence of inducers (with leaky expression from repressed promoters), or without explicit 
promoters at all47,48,90 
One study in the literature compared different combinations of single-copy integration of 
two carotenoid genes from P. ananatis with a third expressed from a plasmid with lac- 
inducible expression89. Multi-copy expression of crtB led to a severe decrease in cellular 
growth and substantially lower levels of lycopene production. The author suggested that 
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CrtB was simply toxic to E. coli when overexpressed; however, induction of crtB was 
never performed in the absence of CrtE and CrtI. Data presented later in this chapter 
suggest that this explanation is not sufficient. An alternative hypothesis that we sought to 
investigate was that imbalanced enzyme expression led to overproduction of the 
intermediate phytoene which was causing the reduction in growth. 
Ultimately, successful overproduction of lycopene has been carried out through various 
metabolic engineering efforts without too much thought to the observed phenomenon of 
growth restriction under gene overexpression. For the purposes of constructing our 
biosensor, however, we were interested in determining an optimal ratio of enzyme 
expression for lycopene production. In chapter two, our plasmid-encoded biosensor had 
extremely low expression of crtEBI, and attempts to clone the operon with medium- or 
high-strength constitutive or inducible promoters repeatedly failed. We thus investigated 
the cause of the apparent toxicity to help determine optimal or at least sufficient 
performance of these genes, which could decrease the time to response for our 
micronutrient biosensor. 
4.2 Results 
We first isolated the coding sequences for CrtE, CrtB, and CrtI, and assembled them with 
a variety of different efficiency ribosomal binding sites (RBSs). Constitutive expression 
of individual carotenoid enzymes with relatively strong combinations of promoter 
strength and RBS efficiency were isolated, as were combinations of CrtE and CrtI; 
however, we were unable to isolate plasmids constitutively expressing both CrtE and 
CrtB in the absence of CrtI. To further investigate these issues and the extreme growth 
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restriction upon induction of crtEIB in the literature, we constructed a test reporter with 
inducible expression of the lycopene biosynthesis pathway. 
 
 
Figure 17: Initial carotenoid experiment demonstrating significant growth 
restriction on induction of crtB with IPTG and comparative growth advantage on 
induction of crtI with ATC in the presence of high, constitutive expression of crtE. 
Error bars indicate standard deviation. 
 
4.2.1 Initial crtEIB induction 
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To test the relative effects of crtB and crtI expression, a plasmid was constructed with 
expression of crtE controlled by a strong, constitutive promoter with a high efficiency 
RBS. crtB and crtI were placed under control of a LacI-regulated promoter and a TetR-
regulated promoter, respectively, with identical weak RBSs on each coding sequence. 
This plasmid was transformed into E. coli DH10B which was grown at varying 
concentrations of ATC and IPTG. We found a strong negative (r=-0.957, p<1x10-8) 
correlation between IPTG concentration (crtB induction) and culture OD600, consistent 
with the previous inability to isolate plasmids cloned with most combinations of crtE and 
crtB expression. Additionally, at all tested concentrations there was a significant decrease 
in optical density between 10 and 50 µM IPTG (Figure 17). Interestingly, for all but the 
highest concentration of IPTG (100 µM, data not shown), there was a trend of increasing 
OD with ATC, with a significant increase in OD at the highest concentration of ATC 
(p<0.05) for each concentration of IPTG. With the highest level of both inducers, these 
conditions should be the most burdensome in terms of heterologous protein expression, 
suggesting that simple transgene expression-dependent stress response was inadequate to 
explain the observed behavior. 
4.2.2 Dual crtEIB and fluorescent reporter induction 
To follow up on the initial apparent growth benefit of co-induction of crtB and crtI 
relative to crtB alone in the presence of CrtE, we constructed a fluorescent reporter 
plasmid using the same induction systems but without any carotenoid biosynthesis genes. 
This construct allowed us to use fluorescence as a simply measured proxy for protein 
expression in the inducible crtB/crtI construct made in the previous section and compare 
it with observed changes in growth. Strains harboring either the fluorescence reporter 
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plasmid or the inducible carotenoid plasmid were cultured under various concentrations 
of inducer, including higher levels of ATC to determine if a higher apparent growth 
rescue could be obtained by increasing crtI expression further. 
We found both a statistically significant negative correlation between eGFP expression 
from IPTG induction (proxy for CrtB) and OD in the carotenoid construct and a 
significant positive correlation between mRFP induction (proxy for CrtI) and OD in the 
carotenoid construct (Table 4), suggesting that, in general, more CrtB resulted in a lower 
optical density, and more CrtI resulted in a higher optical density.  
 
Table 4: Correlation between fluorescence reporters and carotenoid construct 
optical densities. 
 Pearson correlation 
coefficient 
p 















In the carotenoid construct, there was no significant difference in OD between 0 and 50 
ng/mL ATC (CrtI) at all but100 µM IPTG, but at 0, 10, and 50 µM IPTG (CrtB), there 
was an increase in optical density at 100 and 150 ng/mL ATC. No positive effect of ATC 
was observed at 100 µM IPTG. This suggests that for lower expression levels of CrtB, 
 77 
increasing levels of CrtI result in less growth restriction, though there is an apparent limit 
to this effect as it was not observed at the highest induction of CrtB (Figure 18b,d). 
Comparing the carotenoid construct across IPTG concentrations, there is a significant 
reduction in optical density at the highest level of IPTG for all levels of ATC. This 
reduction was dose dependent in the absence of ATC (Figure 18e): intermediate 
induction levels had significantly different optical densities than both the lowest and 
highest induction levels. This suggests that increased levels of crtB are directly 
responsible for the growth restriction. 
Looking at optical density in the fluorescent reporter (Figure 18a), maximal IPTG 
induction significantly decreased the optical density relative to zero-IPTG conditions, but 
only at 0 and 50 ng/mL ATC (Figure 18c). No differences in optical density as a function 
of either inducer appeared to be dose-dependent. In all cases, the differences in growth 
are most pronounced in the carotenoid construct (Figure 18b). 
While it could be expected that inducing significant amounts of protein expression could 
have a detrimental effect on cell growth, even with well tolerated fluorescent reporters, it 
was not expected that there would be significant increases in optical density with 
increasing induction of fluorescent reporter expression as seen in Figure 18a, when at 100 




Figure 18: Optical density of (a) fluorescent reporter and (b) carotenoid construct 
showing induction dependent growth restriction by IPTG and partial rescue by 
ATC. (c) Growth restriction present at highest IPTG in the fluorescent reporter. (d) 
Carotenoid construct growth is enhanced by ATC. (e) Carotenoid construct growth 
shows dose-dependent reduction by IPTG. Error bars denote standard deviation. 





Figure 19: Induction of pigment test construct in the absence of CrtE. No growth 
restriction was observed upon induction of any combination of crtB and crtI. 
Significant (p<0.05) differences were detected at 24 hours, but ODs were strictly 
higher under induction. Error bars indicate standard deviation. ATC induces crtI. 
IPTG induces crtB. 
 
4.2.3 Inducible crtIB, weak crtE inducible crtB 
To investigate whether the cause of the observed growth restriction and partial rescue due 
to induction of crtI and crtB was due to some other effect of proteins alone, a plasmid 
identical to EIB, but lacking constitutive expression of crtE was developed and tested at 
18 and 24 hours (Figure 19). At 18 hours, there was no observable significant difference 
in average OD600 between any induction conditions. At 24 hours, there was a small but 
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significant difference between uninduced and dual-induced and between induction with 
IPTG alone and with both IPTG and ATC; however, all observed induced ODs were 
higher than uninduced, though the difference was not significant for crtB induction alone. 
In no cases was any combination of inducers causing growth restriction. This is an 
interesting result as the metabolic precursor to crtB is not present in these experiments. 
Any enzymatic activity would be nonspecific activity on endogenous E. coli metabolites. 
Whatever the cause of an increase in terminal OD with expression of crtBI, these results 
suggest that the presence of CrtB or CrtI themselves is not causing the observed growth 
restriction in other experiments. The lack of an observable effect of CrtB expression on 
OD does not support suggestions from the literature that CrtB itself is toxic to E. coli.  
It is worth noting that Figure 18 and Figure 19 show different behaviors for terminal OD 
in non-lycopene-producing strains as a function of increasing IPTG induction. A possible 
explanation for the discrepancy in growth disadvantage upon IPTG induction between the 
two constructs is disparities in overall transgene expression burden, as the fluorescent 
reporter has a high-efficiency RBS on eGFP and the carotenoid construct has an RBS 
with approximately 100-fold lower efficiency on crtI. This is not, however, easily 
reconcilable with the disappearance of this effect at dual-induction with IPTG and ATC 
which should be strictly more burdensome. 
To follow up on these findings, constructs with different promoter and RBS strengths on 
crtE were assembled with either weak or strong ribosomal binding sites on IPTG-
inducible crtB. With low expression of crtE, the induction of crtB with a strong RBS 
shows a small, but increasingly significant decrease in OD as a function of IPTG (Figure 
20). The same construct with a 100-fold weaker RBS on crtE shows no change at any 
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IPTG concentrations, suggesting the growth restriction is directly dependent on the 
presence of CrtE. Constitutive expression of crtE with a much stronger promoter alone 
was not an issue. This strongly suggests that the combined presence of CrtE and CrtB is 
responsible for the observed growth restriction in the carotenoid pathway. 
 
 
Figure 20: Induction of crtB with varying constitutive expression of crtE showing 
dependence of growth restriction on presence of high crtE. Error bars indicate 
standard deviation. IPTG induces crtB 
 
4.2.4 Vector and strain controls 
 82 
To ensure that the observed growth restriction was not solely due to the inducers or the 
induction systems alone, we grew DH10B and an empty inducible vector control at the 
same concentrations as above (Figure 21). We observed no significant difference in 
OD600 between inducer concentrations at 18 hours in the DH10B control and no 
difference in the empty vector control except at 360 µM IPTG, which resulted in a slight 
reduction in OD (Figure 21c). At 360 µM IPTG, ATC concentration has no significant 
effect on OD at any IPTG concentration. It is important to note that the growth reduction 
observed at 360 µM IPTG is at a significantly higher IPTG concentration than was used 
in the previous experiments with crtEBI in which induction-dependent growth restriction 
was observed. These controls suggest that the observed reduction in OD in the crtEIB 
experiments is not caused by either a natural response of DH10B to the inducers or by 
binding of inducers to their regulated proteins and alleviation of repression on an empty 
plasmid. 
4.2.5 HPLC investigation of phytoene 
Based on previously published work reporting high carotenoid intermediate yields in 
BL21(DE3)91 (which was inconsistent with our initial hypothesis that phytoene 
accumulation was the source of the growth restriction), we asked whether similar 
experiments in BL21(DE3) might show lower growth restriction, perhaps due to inherent 
differences in intermediate toxicity between strains. To test this, both BL21(DE3) and 
DH10B were transformed with the carotenoid construct and grown overnight in LB 
supplemented with different concentrations of inducers. Acetone extractions were 
performed on combined replicates of samples to ensure a sufficient amount of 
carotenoids for detection on HPLC. 
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Both strains showed growth restriction upon induction with the most profound growth 
restriction observed in DH10B. We detected peaks at 274 nm with a retention 
 
Figure 21: Parent strain and empty vector growth controls. (a) DH10b shows no 
effect of inducers. (b) Empty vector control shows decrease in growth at 360 µM 
IPTG. (c) Empty vector and DH10b at 0, 100 ng/mL ATC. Optical density 
differences only present at 360 µM IPTG in empty vector control. (* p<0.05) Error 





Figure 22: Carotenoid production in BL21 versus DH10B from combined 
extractions. Quantity run on instrument was proportional to culture optical density. 
ATC induces crtI. IPTG induces crtB. 
 
time of 8.9 minutes and a spectrum consistent with phytoene which were highest at IPTG 
only conditions in both strains. Phytoene was undetectable under dual induction in BL21 
and 1.8-fold reduced in DH10B (Figure 22). This is consistent with increased CrtI 
reducing the amount of accumulated phytoene; however, lycopene production apparently 
drops with induction in DH10B, though it increases in BL21(DE3). These results suggest 
that a difference in strain response to phytoene is not the explanation for growth defects, 
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since growth restriction was observed in both BL21(DE3) and DH10B and BL21(DE3) 
has been used to overproduce phytoene in the literature. 
 
Figure 23: DH10B growth in carotenoid extraction experiment. Growth restriction 
and rescue similar to previous experiments. Error bars indicate standard deviation. 
ATC induces crtI. IPTG induces crtB. 
 
To expand upon this, a higher-resolution induction was performed in DH10B at 
increasing concentrations of ATC (0, 100 ng/µL, 200 ng/µL, 400 ng/µL) and IPTG (0 
µM, 90 µM IPTG, 180 µM IPTG, 360 µM IPTG). Again, cell densities decreased 
universally with increasing IPTG (Figure 23). At these higher induction levels, we 
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expected to see an enhanced alleviation of growth restriction upon crtI expression, but 
this effect was not observed.  
 
 
Figure 24: Lycopene production upon induction of crtB, crtI in the presence of 
constitutive crtE. Note the local maximum apparent at 90 µM IPTG at 400 ng/mL 
ATC. Error bars indicate standard deviation. ATC induces crtI. IPTG induces crtB. 
 
At similar IPTG concentrations to previous experiments (90,180 µM IPTG), there were 
statistically significant differences in optical density between cultures with and without 
ATC (growth “rescue”). Indeed, at 180 µM IPTG there was an apparent dose response, 
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with significant differences between the highest and the two lowest ATC concentrations. 
This effect was not observed in the absence of IPTG or at the highest concentration of 
IPTG. In previous experiments, induction of crtI by addition of ATC produced an 
increase in culture density at 0 µM IPTG; however, we failed to observe this effect here.  
 
 
Figure 25: Relative phytoene production as a function of induction of independent 
crtB and crtI. In general, phytoene decreases with increasing CrtI. Error bars 
indicate standard deviation. Replicates from cultures at 180 µM and 360 µM IPTG 
were combined due to low optical density to ensure enough phytoene for detection. 
ATC induces crtI. IPTG induces crtB. 
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While the absence of this effect at 360 µM is also unexpected, it is not inconsistent with 
previous experiments, as 360 µM IPTG is a substantially higher concentration than was 
used in previous experiments. It is interesting to note that based on inductions in the 
fluorescent reporter construct, 360 µM is outside the linear response range of lacI, so crtB 
expression would be expected to be only marginally higher than in the previous 
experiment at 150 µM. 
Acetone extractions were analyzed to determine the effects of enzyme expression on 
lycopene and phytoene accumulation. In order to get enough analyte to measure, 
replicates of samples with the lowest optical densities were combined and extracted. As 
such, no statistics were performed on 180 or 360 µM IPTG carotenoid data, though single 
measurements normalized by the combined optical density are presented. 
Lycopene was strictly higher at the highest ATC concentrations for all concentrations of 
IPTG and, in general, increased with increasing IPTG (Figure 24). The most notable 
exception to that behavior is at 90 µM IPTG and 400 ng/mL ATC, at which there is an 
apparent local maximum for lycopene production per culture optical density. Lycopene at 
these concentrations was significantly higher (p<0.05) than any of the nearest comparable 
measurements for ATC or IPTG concentration. 
Phytoene was either undetectable or lower at the highest ATC concentration in all cases 
except for the absence of IPTG (Figure 25). This is consistent with the expectation that 
higher levels of CrtI would result in a decrease in the precursor phytoene. Phytoene was 
significantly higher at 90 µM IPTG than in the absence of IPTG for all but the highest 
concentration of ATC. Again, this is consistent with increased CrtB production 
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converting more GGPP to phytoene. The absence of this difference at the highest 
concentration of ATC could be attributed to ample CrtI being present to completely 
convert any phytoene produced to lycopene. In support of this, those induction conditions 
resulted in the highest amount of lycopene produced; however, that same relative 
imbalance between CrtB and CrtI levels could reasonably be expected in the absence of 
IPTG as well, and while relatively higher lycopene levels were observed, nonzero levels 
of phytoene were measured in that case as well. 
4.3 Conclusion 
The phytoene measurements in this chapter are also inconsistent with the initial 
hypothesis that the intermediate phytoene was primarily responsible for the observed 
growth restriction. As phytoene levels are nearly universally lower at maximal crtI 
induction, we would expect these conditions to have the most significant rescue of 
growth, yet this is not observed. Indeed, we found no significant correlation between 
measured phytoene levels and optical density. 
We have investigated growth restriction upon differential expression of the carotenoid 
pathway genes crtEIB. Early experiments led us to propose that the intermediate 
phytoene was primarily responsible for this phenomenon, although further analysis 
suggested that the real underlying mechanism is not that simple. Lycopene production is 
well-documented in E. coli, and the accumulation of carotenoids in these experiments is 
far lower than other experiments in the literature, suggesting that simple toxicity of the 
product of this pathway is not the cause. A cofactor imbalance could also cause 
significant stress; however, we showed that the effect primarily depends on the induction 
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of crtB in the presence of CrtE. If a cofactor imbalance were the primary cause, we would 
still expect to observe a correlation between phytoene accumulation and optical density, 
because relative levels of lycopene and phytoene indicate the extent of each intermediate 
reaction and thus presumably cofactor usage. 
Another possibility that we have not investigated is the formation of a relatively insoluble 
protein complex, CrtEB. It is difficult to reconcile the positive effect on optical density 
upon induction of crtI with this model, but it is not completely unreasonable that a third 
protein could stabilize an EB complex; however, we would again expect that increasing 
CrtI should be able to more effectively ameliorate the negative effects of CrtEB if that 
were indeed the explanation, but the capacity for “rescue” of growth restriction seems to 
be limited. 
A final takeaway from these experiments is the local maximum observed in lycopene 
production. In our work on a biosensor, we have constitutively expressed these 
carotenoid genes from operon that was previously available and not deliberately 
balanced. This work suggests that there is an optimal ratio of enzyme expression that 





CHAPTER 5. FUTURE DIRECTIONS 
Here I have presented the development of a whole-cell zinc biosensor based on E. 
coli for the evaluation of zinc status in human serum; however, there remain significant 
steps to translate the work here into a functional, field-deployable device. In this chapter, 
I will discuss immediate next steps to move forward the advances and findings presented 
in this thesis, as well as critical next steps that to move the work from this thesis closer to 
deployment in the field, including possible alternative strategies that may allow 
accelerated implementation. To conclude, I will summarize my contributions and discuss 
them in the context of continued efforts to produce a field-deployable assay. 
5.1 Extension of thesis results 
An important next step is to evaluate the actual zinc concentrations in serum and media 
combinations used in our in experiments to date using currently accepted quantitative 
techniques, such as ICP-MS. In this work, we used a chelating resin to remove zinc from 
serum of indeterminate zinc content. Prior to final tuning, it was sufficient to demonstrate 
differences between treated and untreated serum and serum with or without zinc 
supplementation. This showed that matrix effects of serum would not in principle prevent 
E. coli from differentially responding to zinc in its environment. The quantitative zinc 
levels will be important for final tuning of the response thresholds to zinc levels. 
We have demonstrated here that the sensor response can be manipulated in serum using 
synthetic biology approaches, but the different concentration ranges at which the sensor 
produces different pigments is not yet properly tuned for physiologically relevant 
 92 
concentrations in serum. With information on the actual zinc content of the serum 
samples we are using, the expression of crtY can be fine-tuned to control the switch point 
between lycopene and ß-carotene. To identify improved constructs, the performance of 
plasmids tested in this work can be used in concert with computational tools like the 
Ribosomal Binding Site Calculator to hone in on an acceptable RBS efficiency. The 
efficiency of current constructs can be evaluated in silico and the results used as bounds 
for de novo design of new intermediate efficiency candidates with the same 
computational tool. 
Additionally, similar techniques will be needed to tune PzntA-controlled expression of zur 
in concert with decoy binding sites to adjust the zinc concentrations at which violacein 
production is sufficient to produce a purple sensor output. Based on array loss observed 
in experiments with decoy arrays and pigment reporters, a 32 decoy site array is probably 
too unstable for application in a final device. Experiments titrating down the number of 
decoys in concert with adjustment of the RBS efficiency on zur will be necessary to 
sustain violacein production out to an acceptably high zinc concentration. 
To extend on the work presented here on carotenoid gene toxicity and optimal expression 
for lycopene production, a higher-resolution investigation of a local maximum in 
lycopene could result in improved sensor performance by reducing transgene expression 
required by cells, though it is unclear whether that is strictly necessary. Current efforts 
into improving time-to-response in our lab involve adjusting lycopene production, and 
this approach could be useful in those efforts as well. As it is impractical to use chemical 
inducers for any final device implementation, constitutive expression of carotenoid 
enzymes in the range determined by our induction experiments in Chapter 4 would need 
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to be implemented for integration into the biosensor. Further investigation of CrtB-
dependent toxicity, while scientifically interesting, is likely not necessary for improving 
performance of the sensor. Efforts towards elucidating the mechanism of the growth 
restriction would involve significant work assessing actual protein levels under different 
conditions rather than the convenient fluorescence proxies we used in this work and 
possibly metabolomics work to investigate the impact of enzyme expression and activity 
on native E. coli metabolism. 
5.2 Towards a field-deployable sensor 
Creating a useful device out of the whole-cell sensor I have described requires a few 
crucial steps that fell beyond the scope of this thesis work. For instance, a suitable 
preservation method for the biosensor must be investigated. One of the critical challenges 
that is directly addressed by minimal equipment, on-site assays is elimination of the 
logistical challenges involved in properly transporting blood or other biological samples 
appropriately though areas with poorly developed or maintained infrastructure. Thus, a 
successful device cannot come with its own cold chain requirements or other onerous 
requirements for storage or use. Since cells are typically stored in some sort of 
refrigerated format for later use, a long-term preservation strategy for the biosensor cells 
must be developed and tested. Lyophilization is a well-established method of preserving 
cells. As the strategy I presented here for growing biosensor cells in serum appears to 
involve exhausting the human complement system present in the serum with sufficient 
bacterial load, lyophilization techniques that require high starting cell densities and have 
fairly low percentage cell viability may actually achieve the same end. Cells 
compromised by the lyophilization procedure may still serve as adequate decoys to “soak 
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up” complement proteins and allow the remaining viable cells to grow and respond 
appropriately to zinc in the serum. 
Another alternative to help address long-term storage and transportation requirements is 
to implement the circuitry and sensing elements developed and tuned here for E. coli in 
an alternative bacterial chassis that can sporulate, such as Bacillus subtilis. The bacterial 
endospore is an evolutionarily developed long-term preservation mechanism that is 
naturally robust to changes in many environmental variables, especially desiccation and 
temperature changes92. Proper packaging of bacterial spores could result in a device 
without stringent requirements for storage and transportation. Some examples of whole 
cell biosensors from bacterial endospores exist, including for zinc detection62 (however, 
the intended applications and design of the sensor were substantially different). While 
there are clear advantages to using spore forming bacteria, a number of potential 
challenges would have to be investigated and mitigated. The genetic circuits developed 
here are highly unlikely to work in a plug-and-play manner in a different bacterial host. 
Suitable vectors compatible with the new chassis must also be used, or the circuits must 
be chromosomally integrated. Neither of these issues is particularly challenging, but they 
would almost invariably require re-tuning of the circuitry due to copy number variation. 
Additionally, all of the promoters here are unlikely to function similarly, or perhaps at all, 
in a different host. Other constitutive promoters to control regulator expression and the 
lycopene biosynthesis pathway must be implemented. The promoters PzntA and PznuC 
would have to be engineered to function with the new chassis’ RNAP holoenzyme. 
Finally, while ZntR and Zur are more likely to function, the natural intracellular zinc 
concentration in different bacterial hosts or response of intracellular zinc to changes in 
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the environment may vary, altering the extracellular concentrations that cause differential 
regulation by ZntR and Zur. These challenges could be addressed, but the work would be 
substantial. For this reason, the limits of preservation of E. coli should be exhaustively 
investigated before a decision to switch to a new host is made. 
A third strategy would be to abandon the idea of a “whole-cell” biosensor completely and 
to use cell-free extracts (CFE) produced from E. coli. Briefly, this involves removing the 
cell membrane and genetic material of E. coli, effectively creating a large volume of 
cytoplasm with intact transcriptional and translational machinery. With proper reagent 
supplementation, CFE can be used to express proteins or execute the programs encoded 
in arbitrary genetic circuits. Lyophilization has already been demonstrated as a suitable 
storage strategy for cell-free approaches, and because the cellular machinery of E. coli is 
retained, all of the genetic components in the zinc biosensor should retain their native 
functions. Nevertheless, the circuitry would still likely need to be retuned to respond 
appropriately at the desired zinc levels, and this strategy would introduce new variables 
that would also need to be tuned or explored, including the appropriate amount of DNA 
added per volume of CFE and methods to mitigate batch to batch variation in 
functionality of the CFE—both of which could decrease the robustness of any ultimate 
device. Additionally, the strategy I employed in designing the whole-cell sensor relies on 
sensing mechanisms that respond to extracellular zinc downstream of a complex cascade 
of biological interactions that affect the mapping of extracellular zinc to intracellular 
zinc. Indeed, both transcription factors used here have been reported to respond to 
femtomolar levels of zinc in vitro, making it uncertain whether they could be useful in a 
CFE-based zinc assay with serum added directly to the cell-free extract. One approach to 
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circumventing this issue may be to express a subset of additional zinc-binding proteins 
naturally present within the cell to mimic the protein-bound zinc pool in which the 
proteins evolved to function. 
A logical expansion to the work here would be the introduction of sensing components 
for different micronutrients. During my time in graduate school, I had the opportunity to 
participate in the NSF-sponsored I-Corps program during which I met with leaders in the 
field of global micronutrient health and organizations involved in monitoring population 
micronutrient status. Conversations with program directors at the Demographic and 
Health Surveys program funded by USAID suggested that a device similar to the one 
envisioned here that incorporated an assay for even one additional micronutrient would 
be very likely to be included in DHS surveys. Prospective adoption of an assay would go 
a long way towards getting a device actually manufactured and commercialized. Obvious 
candidates for other assays to pursue would be for the remaining micronutrients in the 
NIH’s BOND program: iron, vitamin A, folate, and vitamin B12. 
5.3 Closing remarks 
In this thesis, I have described my efforts to implement a whole-cell bacterial biosensor 
to be used as an assay for zinc levels in human serum. The work I have done 
demonstrates the feasibility of using these sensing components and E. coli as the basis for 
a useful device. 
I demonstrated that PzntA/ZntR could be coupled with the carotenoid pathway to produce 
orange and red sensor output by controlling the transition from lycopene to ß-carotene, 
and that this transition could be tuned to occur over zinc ranges that were physiologically 
 97 
relevant. I demonstrated that violacein production could be controlled over a 
physiologically-relevant zinc concentration range by the use of PznuC and Zur and arrays 
of decoy Zur operators. Furthermore, I combined these systems and demonstrated growth 
and sensor response in human serum. Though the concentration at which each color state 
is induced in serum is not yet optimal for an assay for human zinc status, the ultimate 
form factor of such an assay and preservation method selected for the biosensor will 
almost certainly necessitate additional tuning of the sensor anyway, and the methods I 
employed here can be used to perform that tuning. Additionally, the quantitative 
characterization of the two zinc-responsive promoters with fluorescence coupled with 
data on which zinc concentrations trigger changes in pigmentation in the carotenoid 
pathway allow others to more easily use these pathways as reporting mechanisms with 
different sensors. As long as the ultimate output of the sensing mechanism is 
transcriptional, performance of an arbitrary sensor can be investigated in fluorescence 
space and compared against the data presented here, facilitating selection of post-
transcriptional regulatory features to enable color switching from lycopene to ß-carotene 
over a novel concentration range of interest. This allows the reporting machinery used in 
these experiments to be easily ported to other synthetic biology applications for which 
differential pigment production would be useful. Finally, I investigated expression of 
carotenoid pathway genes and found that models to explain widely reported growth 
restriction were inadequate; I also identified the existence of a local maximum in 
lycopene production at specific induction levels of CrtB and CrtI, which can be used to 
further improve the biosensor or carotenoid synthesis in other applications. 
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Through both my scientific work in the lab and practical, nonscientific engagement with 
policy makers and prospective end users, it became apparent over the course of my 
project that a successful device would require more effort than was feasible for a single 
graduate student. Fortunately, my lab is continuing to develop these ideas and it is my 
hope that my efforts will help lead to a practical, field deployed device to help scientists 
and policymakers addressing pressing global health issues.  
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APPENDIX A. SUPPLEMENTARY FIGURES 
 
Figure 26: Streak from a zinc gradient plate demonstrating direct transition from 
purple to orange without an intervening lycopene-dominated, red state. This is the 
original image from Figure 2C before any contrast adjustment. 
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Figure 27: The visible induction regimes of PzntA and PznuC do not overlap. The plate 
is a zinc gradient plate, with [Zn2+] increasing to the left. The top strain has PznuC 
driving expression of mRFP, while the bottom strain has PzntA driving expression of 
mRFP. Based on expression visible to the naked eye, there is a regime where each 
promoter has low expression. This suggested the possibility that the expression of 
pigment-producing enzymes from either of these promoters would yield non-






1 Mabey, D., Peeling, R. W., Ustianowski, A. & Perkins, M. D. Tropical infectious 
diseases: Diagnostics for the developing world. Nat Rev Micro 2, 231-240 (2004). 
2 Wessells, K. R. & Brown, K. H. Estimating the Global Prevalence of Zinc 
Deficiency: Results Based on Zinc Availability in National Food Supplies and the 
Prevalence of Stunting. PLoS ONE 7, e50568, doi:10.1371/journal.pone.0050568 
(2012). 
3 Black, R. E. Maternal and child undernutrition: global and regional exposures and 
health consequences. The Lancet 371, doi:10.1016/S0140-6736(07)61690-0 
(2008). 
4 King, J. C. Determinants of maternal zinc status during pregnancy. American 
Journal of Clinical Nutrition (2000). 
5 UNICEF/WHO. Diarrhoea: Why children are still dying and what can be done. 
(2009). 
6 Black, R. E. et al. Maternal and child undernutrition and overweight in low-
income and middle-income countries. The Lancet, doi:10.1016/s0140-
6736(13)60937-x (2013). 
7 Wapnir, R. A. Zinc deficiency, malnutrition and the gastrointestinal tract. The 
Journal of nutrition 130, 1388S-1392S (2000). 
8 Hess, S. Y., Peerson, J. M., King, J. C. & Brown, K. H. Use of serum zinc 
concentration as an indicator of population zinc status. Food Nutr Bull 28, S403-
429, doi:10.1177/15648265070283s303 (2007). 
9 Ye, X. A.-B., S. Kloti,A.  Zhang, J.  Lucca, P.  Beyer, P.  Potrykus, I. Engineering 
the Provitamin A (B-Carotene) Biosynthetic Pathway into (Carotenoid-Free) Rice 
Endosperm. Science 287 (2000). 
10 Beyer, P. A.-B., S.  Ye, X.  Lucca, P.  Schuabl, P.  Welsch, R.  Potrykus, Ingo. 
Golden Rice:  Introducing the B-Carotene Biosynthesis Pathway into Rice 
Endosperm by Genetic Engineering to Defeat Vitamin A Deficiency. American 
Society for Nutritional Sciences (2002). 
11 Ruel, M. T. & Alderman, H. Nutrition-sensitive interventions and programmes: 
how can they help to accelerate progress in improving maternal and child 
nutrition? The Lancet, doi:10.1016/s0140-6736(13)60843-0 (2013). 
 102 
12 Brown, K. H., Peerson, J M, Baker, S K,  Hess, S Y. Preventive zinc 
supllementation among infants, preschoolers, and older prepubertal childern. 
Food and Nutrition Bulletin 30, 29 (2009). 
13 Yakoob, M. Y. et al. Preventive zinc supplementation in developing countries: 
impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC 
public health 11 Suppl 3, S23, doi:10.1186/1471-2458-11-S3-S23 (2011). 
14 Soofi, S. et al. Effect of provision of daily zinc and iron with several 
micronutrients on growth and morbidity among young children in Pakistan: a 
cluster-randomised trial. The Lancet 382, 29-40, doi:10.1016/s0140-
6736(13)60437-7 (2013). 
15 Imdad, A. & Bhutta, Z. A. Effect of preventive zinc supplementation on linear 
growth in children under 5 years of age in developing countries: a meta-analysis 
of studies for input to the lives saved tool. BMC public health 11 Suppl 3, S22, 
doi:10.1186/1471-2458-11-S3-S22 (2011). 
16 Mission, J. a. K. N. R. H. Operational Guidelines for State Programme 
Implementation Plan.  (2012). 
17 Bhutta, Z. A. et al. Evidence-based interventions for improvement of maternal 
and child nutrition: what can be done and at what cost? The Lancet, 
doi:10.1016/s0140-6736(13)60996-4 (2013). 
18 Keasling, J. D. Synthetic Biology for Synthetic Chemistry. ACS Chemical Biology 
3, 64-76, doi:10.1021/cb7002434 (2008). 
19 Gardner, T. S., Cantor, C. R. & Collins, J. J. Construction of a genetic toggle 
switch in Escherichia coli. Nature 403, 339-342, doi:10.1038/35002131 (2000). 
20 Tamsir, A., Tabor, J. J. & Voigt, C. A. Robust multicellular computing using 
genetically encoded NOR gates and chemical /`wires/'. Nature 469, 212-215, 
doi:http://www.nature.com/nature/journal/v469/n7329/abs/nature09565.html#sup
plementary-information (2011). 
21 Leth, S. et al. Engineered Bacteria Based Biosensors for Monitoring Bioavailable 
Heavy Metals. Electroanalysis 14, 35-42, doi:10.1002/1521-
4109(200201)14:1<35::AID-ELAN35>3.0.CO;2-W (2002). 
22 Charrier, T. et al. A multi-channel bioluminescent bacterial biosensor for the on-
line detection of metals and toxicity. Part I: design and optimization of 
bioluminescent bacterial strains. Analytical and bioanalytical chemistry 400, 
1051-1060, doi:10.1007/s00216-010-4353-9 (2011). 
23 Daunert, S. et al. Genetically engineered whole-cell sensing systems: coupling 
biological recognition with reporter genes. Chemical reviews 100, 2705-2738 
(2000). 
 103 
24 Olaniran, A. O., Hiralal, L. & Pillay, B. Whole-cell bacterial biosensors for rapid 
and effective monitoring of heavy metals and inorganic pollutants in wastewater. 
Journal of environmental monitoring : JEM 13, 2914-2920, 
doi:10.1039/c1em10032g (2011). 
25 Jouanneau, S., Durand, M. J. & Thouand, G. Online detection of metals in 
environmental samples: comparing two concepts of bioluminescent bacterial 
biosensors. Environmental science & technology 46, 11979-11987, 
doi:10.1021/es3024918 (2012). 
26 Gierach, I., Li, J., Wu, W. Y., Grover, G. J. & Wood, D. W. Bacterial biosensors 
for screening isoform-selective ligands for human thyroid receptors alpha-1 and 
beta-1. FEBS open bio 2, 247-253, doi:10.1016/j.fob.2012.08.002 (2012). 
27 Weber, W. & Fussenegger, M. The impact of synthetic biology on drug 
discovery. Drug discovery today 14, 956-963, doi:10.1016/j.drudis.2009.06.010 
(2009). 
28 Looger, L. L., Dwyer, M. A., Smith, J. J. & Hellinga, H. W. Computational 
design of receptor and sensor proteins with novel functions. Nature 423, 185-190, 
doi:10.1038/nature01556 (2003). 
29 Beggah, S., Vogne, C., Zenaro, E. & Van Der Meer, J. R. Mutant HbpR 
transcription activator isolation for 2-chlorobiphenyl via green fluorescent 
protein-based flow cytometry and cell sorting. Microbial biotechnology 1, 68-78, 
doi:10.1111/j.1751-7915.2007.00008.x (2008). 
30 Alper, H., Fischer, C., Nevoigt, E. & Stephanopoulos, G. Tuning genetic control 
through promoter engineering. Proceedings of the National Academy of Sciences 
of the United States of America 102, 12678-12683, doi:10.1073/pnas.0504604102 
(2005). 
31 Brocklehurst, K. R. et al. ZntR is a Zn(II)-responsive MerR-like transcriptional 
regulator of zntA in Escherichia coli. Molecular microbiology 31, 893-902 
(1999). 
32 Busenlehner, L. S., Pennella, M. A. & Giedroc, D. P. The SmtB/ArsR family of 
metalloregulatory transcriptional repressors: structural insights into prokaryotic 
metal resistance. FEMS Microbiology Reviews 27, 131-143, doi:10.1016/s0168-
6445(03)00054-8 (2003). 
33 Yong, Y.-C. & Zhong, J.-J. A genetically engineered whole-cell pigment-based 
bacterial biosensing system for quantification of N-butyryl homoserine lactone 
quorum sensing signal. Biosensors and Bioelectronics 25, 41-47, 
doi:http://dx.doi.org/10.1016/j.bios.2009.06.010 (2009). 
34 Yoshida, K. et al. Novel carotenoid-based biosensor for simple visual detection of 
arsenite: characterization and preliminary evaluation for environmental 
 104 
application. Applied and environmental microbiology 74, 6730-6738, 
doi:10.1128/aem.00498-08 (2008). 
35 Lee, L. J., Barrett, J. A. & Poole, R. K. Genome-wide transcriptional response of 
chemostat-cultured Escherichia coli to zinc. Journal of bacteriology 187, 1124-
1134, doi:10.1128/JB.187.3.1124-1134.2005 (2005). 
36 Wang, D., Hosteen, O. & Fierke, C. A. ZntR-mediated transcription of zntA 
responds to nanomolar intracellular free zinc. Journal of inorganic biochemistry 
111, 173-181, doi:10.1016/j.jinorgbio.2012.02.008 (2012). 
37 Graham, A. I. et al. Severe zinc depletion of Escherichia coli: roles for high 
affinity zinc binding by ZinT, zinc transport and zinc-independent proteins. The 
Journal of biological chemistry 284, 18377-18389, doi:10.1074/jbc.M109.001503 
(2009). 
38 Yamamoto, K. & Ishihama, A. Transcriptional response of Escherichia coli to 
external zinc. Journal of bacteriology 187, 6333-6340, 
doi:10.1128/JB.187.18.6333-6340.2005 (2005). 
39 Easton, J. A., Thompson, P. & Crowder, M. W. Time-dependent translational 
response of E. coli to excess Zn(II). Journal of biomolecular techniques : JBT 17, 
303-307 (2006). 
40 Sigdel, T. K. et al. Probing the adaptive response of Escherichia coli to 
extracellular Zn(II). Biometals : an international journal on the role of metal ions 
in biology, biochemistry, and medicine 19, 461-471, doi:10.1007/s10534-005-
4962-5 (2006). 
41 Gireesh-Babu, P. & Chaudhari, A. Development of a broad-spectrum fluorescent 
heavy metal bacterial biosensor. Molecular biology reports 39, 11225-11229, 
doi:10.1007/s11033-012-2033-x (2012). 
42 Michelini, E. et al. Field-deployable whole-cell bioluminescent biosensors: so 
near and yet so far. Analytical and bioanalytical chemistry 405, 6155-6163, 
doi:10.1007/s00216-013-7043-6 (2013). 
43 Pemberton, J., Vincent, K. & Penfold, R. Cloning and heterologous expression of 
the violacein biosynthesis gene cluster fromChromobacterium violaceum. Current 
Microbiology 22, 355-358, doi:10.1007/BF02092154 (1991). 
44 Duran, N. et al. Violacein: properties and biological activities. Biotechnology and 
applied biochemistry 48, 127-133, doi:10.1042/BA20070115 (2007). 
45 Hoshino, T. Violacein and related tryptophan metabolites produced by 
Chromobacterium violaceum: biosynthetic mechanism and pathway for 
construction of violacein core. Applied microbiology and biotechnology 91, 1463-
1475, doi:10.1007/s00253-011-3468-z (2011). 
 105 
46 Ahmetagic, A. & Pemberton, J. M. Stable high level expression of the violacein 
indolocarbazole anti-tumour gene cluster and the Streptomyces lividans amyA 
gene in E. coli K12. Plasmid 63, 79-85, doi:10.1016/j.plasmid.2009.11.004 
(2010). 
47 Alper, H., Jin, Y. S., Moxley, J. F. & Stephanopoulos, G. Identifying gene targets 
for the metabolic engineering of lycopene biosynthesis in Escherichia coli. 
Metabolic engineering 7, 155-164, doi:10.1016/j.ymben.2004.12.003 (2005). 
48 Jin, Y. S. & Stephanopoulos, G. Multi-dimensional gene target search for 
improving lycopene biosynthesis in Escherichia coli. Metabolic engineering 9, 
337-347, doi:10.1016/j.ymben.2007.03.003 (2007). 
49 Pitera, D. J., Paddon, C. J., Newman, J. D. & Keasling, J. D. Balancing a 
heterologous mevalonate pathway for improved isoprenoid production in 
Escherichia coli. Metabolic engineering 9, 193-207, 
doi:10.1016/j.ymben.2006.11.002 (2007). 
50 Ajikumar, P. K. et al. Isoprenoid pathway optimization for Taxol precursor 
overproduction in Escherichia coli. Science 330, 70-74, 
doi:10.1126/science.1191652 (2010). 
51 Wong, A. P., Gupta, M., Shevkoplyas, S. S. & Whitesides, G. M. Egg beater as 
centrifuge: isolating human blood plasma from whole blood in resource-poor 
settings. Lab on a Chip 8, 2032-2037, doi:10.1039/B809830C (2008). 
52 Bhamla, M. S. et al. Hand-powered ultralow-cost paper centrifuge.  1, 0009, 
doi:10.1038/s41551-016-0009 (2017). 
53 Yang, X., Forouzan, O., Brown, T. P. & Shevkoplyas, S. S. Integrated separation 
of blood plasma from whole blood for microfluidic paper-based analytical 
devices. Lab on a Chip 12, 274-280, doi:10.1039/C1LC20803A (2012). 
54 Watstein, D. M., McNerney, M. P. & Styczynski, M. P. Precise metabolic 
engineering of carotenoid biosynthesis in Escherichia coli towards a low-cost 
biosensor. Metabolic engineering 31, 171-180, doi:10.1016/j.ymben.2015.06.007 
(2015). 
55 Atsumi, S. et al. Metabolic engineering of Escherichia coli for 1-butanol 
production. Metabolic engineering 10, 305-311, 
doi:http://dx.doi.org/10.1016/j.ymben.2007.08.003 (2008). 
56 Atsumi, S., Hanai, T. & Liao, J. C. Non-fermentative pathways for synthesis of 
branched-chain higher alcohols as biofuels. Nature 451, 86-89, 
doi:10.1038/nature06450 (2008). 
57 Jin, Y. S., Alper, H., Yang, Y. T. & Stephanopoulos, G. Improvement of xylose 
uptake and ethanol production in recombinant Saccharomyces cerevisiae through 
 106 
an inverse metabolic engineering approach. Applied and environmental 
microbiology 71, 8249-8256, doi:10.1128/aem.71.12.8249-8256.2005 (2005). 
58 Alonso-Gutierrez, J. et al. Metabolic engineering of Escherichia coli for limonene 
and perillyl alcohol production. Metabolic engineering 19, 33-41, 
doi:10.1016/j.ymben.2013.05.004 (2013). 
59 Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid in 
engineered yeast. Nature 440, 940-943, doi:10.1038/nature04640 (2006). 
60 Chemler, J. A., Fowler, Z. L., McHugh, K. P. & Koffas, M. A. Improving 
NADPH availability for natural product biosynthesis in Escherichia coli by 
metabolic engineering. Metabolic engineering 12, 96-104, 
doi:10.1016/j.ymben.2009.07.003 (2010). 
61 Raab, A. M., Gebhardt, G., Bolotina, N., Weuster-Botz, D. & Lang, C. Metabolic 
engineering of Saccharomyces cerevisiae for the biotechnological production of 
succinic acid. Metabolic engineering 12, 518-525, 
doi:10.1016/j.ymben.2010.08.005 (2010). 
62 Date, A., Pasini, P. & Daunert, S. Integration of spore-based genetically 
engineered whole-cell sensing systems into portable centrifugal microfluidic 
platforms. Analytical and bioanalytical chemistry 398, 349-356, 
doi:10.1007/s00216-010-3930-2 (2010). 
63 Farmer, W. R. & Liao, J. C. Precursor balancing for metabolic engineering of 
lycopene production in Escherichia coli. Biotechnol Prog 17, 57-61, 
doi:10.1021/bp000137t (2001). 
64 Yoon, S. H. et al. Enhanced lycopene production in Escherichia coli engineered to 
synthesize isopentenyl diphosphate and dimethylallyl diphosphate from 
mevalonate. Biotechnology and bioengineering 94, 1025-1032, 
doi:10.1002/bit.20912 (2006). 
65 Alper, H., Miyaoku, K. & Stephanopoulos, G. Construction of lycopene-
overproducing E. coli strains by combining systematic and combinatorial gene 
knockout targets. Nature biotechnology 23, 612-616, doi:10.1038/nbt1083 (2005). 
66 Rodrigues, A. L. et al. Systems metabolic engineering of Escherichia coli for 
production of the antitumor drugs violacein and deoxyviolacein. Metabolic 
engineering 20, 29-41, doi:10.1016/j.ymben.2013.08.004 (2013). 
67 Lee, M. E., Aswani, A., Han, A. S., Tomlin, C. J. & Dueber, J. E. Expression-
level optimization of a multi-enzyme pathway in the absence of a high-throughput 
assay. Nucleic acids research 41, 10668-10678, doi:10.1093/nar/gkt809 (2013). 
68 Fang, M. Y. et al. High crude violacein production from glucose by Escherichia 
coli engineered with interactive control of tryptophan pathway and violacein 
 107 
biosynthetic pathway. Microbial cell factories 14, 8, doi:10.1186/s12934-015-
0192-x (2015). 
69 Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several 
hundred kilobases. Nat Meth 6, 343-345, 
doi:http://www.nature.com/nmeth/journal/v6/n5/suppinfo/nmeth.1318_S1.html 
(2009). 
70 Wong, A. P., Gupta, M., Shevkoplyas, S. S. & Whitesides, G. M. Egg beater as 
centrifuge: isolating human blood plasma from whole blood in resource-poor 
settings. Lab on a chip 8, 2032-2037, doi:10.1039/b809830c (2008). 
71 McGinness, K. E., Baker, T. A. & Sauer, R. T. Engineering Controllable Protein 
Degradation. Molecular Cell 22, 701-707, 
doi:http://dx.doi.org/10.1016/j.molcel.2006.04.027 (2006). 
72 Khan, S., Brocklehurst, K. R., Jones, G. W. & Morby, A. P. The functional 
analysis of directed amino-acid alterations in ZntR from Escherichia coli. 
Biochemical and biophysical research communications 299, 438-445 (2002). 
73 Solomon, K. V., Sanders, T. M. & Prather, K. L. A dynamic metabolite valve for 
the control of central carbon metabolism. Metabolic engineering 14, 661-671, 
doi:10.1016/j.ymben.2012.08.006 (2012). 
74 Soma, Y., Tsuruno, K., Wada, M., Yokota, A. & Hanai, T. Metabolic flux 
redirection from a central metabolic pathway toward a synthetic pathway using a 
metabolic toggle switch. Metabolic engineering 23, 175-184, 
doi:10.1016/j.ymben.2014.02.008 (2014). 
75 Torella, J. P. et al. Tailored fatty acid synthesis via dynamic control of fatty acid 
elongation. Proceedings of the National Academy of Sciences of the United States 
of America 110, 11290-11295, doi:10.1073/pnas.1307129110 (2013). 
76 Zalatan, J. G. et al. Engineering complex synthetic transcriptional programs with 
CRISPR RNA scaffolds. Cell 160, 339-350, doi:10.1016/j.cell.2014.11.052 
(2015). 
77 Anesiadis, N., Cluett, W. R. & Mahadevan, R. Dynamic metabolic engineering 
for increasing bioprocess productivity. Metabolic engineering 10, 255-266, 
doi:10.1016/j.ymben.2008.06.004 (2008). 
78 Callura, J. M., Cantor, C. R. & Collins, J. J. Genetic switchboard for synthetic 
biology applications. Proceedings of the National Academy of Sciences of the 
United States of America 109, 5850-5855, doi:10.1073/pnas.1203808109 (2012). 
79 Kobayashi, H. et al. Programmable cells: interfacing natural and engineered gene 
networks. Proceedings of the National Academy of Sciences of the United States 
of America 101, 8414-8419, doi:10.1073/pnas.0402940101 (2004). 
 108 
80 Tsao, C. Y., Hooshangi, S., Wu, H. C., Valdes, J. J. & Bentley, W. E. 
Autonomous induction of recombinant proteins by minimally rewiring native 
quorum sensing regulon of E. coli. Metabolic engineering 12, 291-297, 
doi:10.1016/j.ymben.2010.01.002 (2010). 
81 Williams, T. C. et al. Quorum-sensing linked RNA interference for dynamic 
metabolic pathway control in Saccharomyces cerevisiae. Metabolic engineering 
29, 124-134, doi:10.1016/j.ymben.2015.03.008 (2015). 
82 McNerney, M. P., Watstein, D. M. & Styczynski, M. P. Precision metabolic 
engineering: The design of responsive, selective, and controllable metabolic 
systems. Metabolic engineering 31, 123-131, doi:10.1016/j.ymben.2015.06.011 
(2015). 
83 Espah Borujeni, A., Channarasappa, A. S. & Salis, H. M. Translation rate is 
controlled by coupled trade-offs between site accessibility, selective RNA 
unfolding and sliding at upstream standby sites. Nucleic Acids Research 42, 2646-
2659, doi:10.1093/nar/gkt1139 (2014). 
84 Outten, C. E. & O'Halloran, T. V. Femtomolar sensitivity of metalloregulatory 
proteins controlling zinc homeostasis. Science 292, 2488-2492, 
doi:10.1126/science.1060331 (2001). 
85 Gilston, B. A. et al. Structural and Mechanistic Basis of Zinc Regulation Across 
the E. coli Zur Regulon. PLoS Biology 12, e1001987, 
doi:10.1371/journal.pbio.1001987 (2014). 
86 King, J. C. et al. Biomarkers of Nutrition for Development (BOND)-Zinc Review. 
The Journal of nutrition, doi:10.3945/jn.115.220079 (2016). 
87 Dunkelberger, J. R. & Song, W. C. Complement and its role in innate and 
adaptive immune responses. Cell research 20, 34-50, doi:10.1038/cr.2009.139 
(2010). 
88 Linscott, W. D. & Triglia, R. P. The bovine complement system. Advances in 
experimental medicine and biology 137, 413-430 (1981). 
89 Albermann, C. High versus low level expression of the lycopene biosynthesis 
genes from Pantoea ananatis in Escherichia coli. Biotechnology letters 33, 313-
319, doi:10.1007/s10529-010-0422-6 (2011). 
90 Cunningham, F. X., Jr., Sun, Z., Chamovitz, D., Hirschberg, J. & Gantt, E. 
Molecular structure and enzymatic function of lycopene cyclase from the 
cyanobacterium Synechococcus sp strain PCC7942. The Plant cell 6, 1107-1121, 
doi:10.1105/tpc.6.8.1107 (1994). 
91 Lu, C.-H., Choi, J.-H., Moran, N. E., Jin, Y.-S. & Erdman, J. W. Laboratory-Scale 
Production of (13)C-Labeled Lycopene and Phytoene by Bioengineered 
 109 
Escherichia coli. Journal of agricultural and food chemistry 59, 9996-10005, 
doi:10.1021/jf202599z (2011). 
92 Nicholson, W. L., Munakata, N., Horneck, G., Melosh, H. J. & Setlow, P. 
Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial 
environments. Microbiology and molecular biology reviews : MMBR 64, 548-572 
(2000). 
 
 
